: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

Flying Publisher

COVID-19: Daily Top 10 Papers

Autoimmune Disorders

Free Subscription

Articles published in Neurology
Retrieve available abstracts of 531 articles:
HTML format

Single Articles

July 2021

RASMINSKY M
GCA Squared.
Neurology. 2021;97:90-91.
PubMed

NICHOLAS RS, Rhone EE, Mariottini A, Silber E, et al
Autologous Haematopoietic Stem Cell Transplantation in Active Multiple Sclerosis: a Real-world Case Series.
Neurology. 2021 Jul 12. pii: WNL.0000000000012449.
PubMed Abstract available

LISAK RP
[Editorial] At the Junction Where It Happens: Antibodies to LRP4 and Agrin Are Pathogenic in Myasthenia Gravis [re: M/S #2020/169756].
Neurology. 2021 Jul 7. pii: WNL.0000000000012471.
PubMed

YU Z, Zhang M, Jing H, Chen P, et al
Characterization of LRP4/Agrin Antibodies From a Patient with Myasthenia Gravis.
Neurology. 2021 Jul 7. pii: WNL.0000000000012463.
PubMed Abstract available

HACOHEN Y, Kerr W, Waters P
Intrathecal Production of MOG-IgG: Highlighting the Need for CSF Testing in Clinical Practice.
Neurology. 2021;97:12-13.
PubMed

June 2021

GRAY-RONCAL K, Fitzgerald K, Ryerson LZ, Charvet L, et al
Association of Disease Severity and Socioeconomic Status in Black and White Americans With Multiple Sclerosis.
Neurology. 2021 Jun 30. pii: WNL.0000000000012362.
PubMed Abstract available

ROOS I, Leray E, Casey R, Horakova D, et al
Effects of High and Low Efficacy Therapy in Secondary Progressive Multiple Sclerosis.
Neurology. 2021 Jun 30. pii: WNL.0000000000012354.
PubMed Abstract available

MYERS KA
Author Response: Teaching Video NeuroImages: Pathologic Yawning: A Sign of Brainstem Involvement in Acute Disseminated Encephalomyelitis?
Neurology. 2021;96:1105.
PubMed

FUJIMORI J, Nakashima I
Reader Response: Teaching Video NeuroImages: Pathologic Yawning: A Sign of Brainstem Involvement in Acute Disseminated Encephalomyelitis?
Neurology. 2021;96:1104-1105.
PubMed

VILLACIEROS-ALVAREZ J, Ordas CM, Torres-Gaona G, Diez-Barrio A, et al
Teaching Video NeuroImages: Anti-IgLON5 Disease: A Long-Course Presentation With a Response to Immunotherapy.
Neurology. 2021;96:e2901-e2902.
PubMed

HUISKAMP M, Eijlers AJC, Broeders TAA, Pasteuning J, et al
Longitudinal Network Changes and Conversion to Cognitive Impairment in Multiple Sclerosis.
Neurology. 2021 Jun 7. pii: WNL.0000000000012341.
PubMed Abstract available

PREZIOSA P, Schoonheim MM
Ongoing Axonal Injury in Chronic Active Lesions in Multiple Sclerosis: In-Vivo Quantification Using Serum Neurofilament.
Neurology. 2021 Jun 4. pii: WNL.0000000000012331.
PubMed

CAMPBELL CREE BA, Arnold DL, Chataway J, Chitnis T, et al
Secondary Progressive Multiple Sclerosis: New Insights.
Neurology. 2021 Jun 4. pii: WNL.0000000000012323.
PubMed Abstract available

MAGGI P, Kuhle J, Schadelin S, van der Meer F, et al
Chronic White Matter Inflammation and Serum Neurofilament Levels in Multiple Sclerosis.
Neurology. 2021 Jun 4. pii: WNL.0000000000012326.
PubMed Abstract available

May 2021

SAN MARTIN AH, Cuadrado CA, Arbizu MG, Rabano-Suarez P, et al
Autoimmune Septin-5 Disease Presenting as Spinocerebellar Ataxia and Nystagmus.
Neurology. 2021 May 24. pii: WNL.0000000000012240.
PubMed

ROLLOT F, Fauvernier M, Uhry Z, Vukusic S, et al
Effects of Age and Disease Duration on Excess Mortality in Patients With Multiple Sclerosis From a French Nationwide Cohort.
Neurology. 2021 May 19. pii: WNL.0000000000012224.
PubMed Abstract available

MARRIE RA, Maxwell C, Mahar A, Ekuma O, et al
Breast Cancer Survival in Multiple Sclerosis: A Matched Cohort Study.
Neurology. 2021 May 19. pii: WNL.0000000000012127.
PubMed Abstract available

TOOSY AT, Kapur K, Nair KV
Is OCT a Viable Tool to Monitor Disease-Modifying Treatments in RRMS Yet?
Neurology. 2021;96:927-928.
PubMed

DAY GS, Yarbrough MY, Kortvelyessy P, Pruss H, et al
Prospective Quantification of CSF Biomarkers in Antibody-Mediated Encephalitis.
Neurology. 2021;96:e2546-e2557.
PubMed Abstract available

TITULAER MJ, Day GS
Autoimmune Encephalitis in First Episode Psychoses: All Smoke and No Fire?
Neurology. 2021 May 12. pii: WNL.0000000000012195.
PubMed

GIANNOCCARO MP, Liguori R
Author Response: Comparison of Ice Pack Test and Single-Fiber EMG Diagnostic Accuracy in Patients Referred for Myasthenic Ptosis.
Neurology. 2021;96:918-919.
PubMed

SILVESTRI N
Reader Response: Comparison of Ice Pack Test and Single-Fiber EMG Diagnostic Accuracy in Patients Referred for Myasthenic Ptosis.
Neurology. 2021;96:918.
PubMed

NERSESJAN V, McWilliam O, Krarup LH, Kondziella D, et al
Autoimmune Encephalitis Related to Cancer Treatment With Immune Checkpoint Inhibitors: Systematic Review.
Neurology. 2021 May 5. pii: WNL.0000000000012122.
PubMed Abstract available

Long-term Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis.
Neurology. 2021 May 4. pii: WNL.0000000000011825.
PubMed

SOLIS-PAZMINO P, Baiu I, Lincango-Naranjo E, Trope W, et al
Impact of the Surgical Approach to Thymectomy Upon Complete Stable Remission Rates in Myasthenia Gravis: A Meta-analysis.
Neurology. 2021 May 4. pii: WNL.0000000000012153.
PubMed Abstract available

FOX RJ, Kryscio RJ
A New Way to Identify Promising Therapies for Progressive Multiple Sclerosis.
Neurology. 2021;96:833-834.
PubMed

KOCH MW, Sage K, Kaur S, Kim J, et al
Repurposing Domperidone in Secondary Progressive Multiple Sclerosis: A Simon 2-Stage Phase 2 Futility Trial.
Neurology. 2021;96:e2313-e2322.
PubMed Abstract available

BAR-OR A, Herman A, Stokmaier D
Author Response: Effect of Ocrelizumab on Vaccine Responses in Patients With Multiple Sclerosis: The VELOCE Study.
Neurology. 2021;96:870.
PubMed

HAHN N
Reader Response: Effect of Ocrelizumab on Vaccine Responses in Patients With Multiple Sclerosis: The VELOCE Study.
Neurology. 2021;96:870.
PubMed

SIEGLER JE, Galetta S
Editors' Note: Effect of Ocrelizumab on Vaccine Responses in Patients With Multiple Sclerosis: The VELOCE Study.
Neurology. 2021;96:869.
PubMed

April 2021

DUBESSY AL, Tezenas du Montcel S, Viala F, Assouad R, et al
Association of Central Hypersomnia and Fatigue in Patients With Multiple Sclerosis: A Polysomnographic Study.
Neurology. 2021 Apr 30. pii: WNL.0000000000012120.
PubMed Abstract available

ZOUVELOU V, Daponte A
Teaching Video NeuroImages: Resolution of Ptosis After Forceful Eye Closure: Bedside Diagnosis of Myasthenia Gravis.
Neurology. 2021 Apr 30. pii: WNL.0000000000012100.
PubMed

LEAVITT VM, Dobson R, Svennigsson A
Perinatal Depression and Anxiety in Multiple Sclerosis: Treatable Distress.
Neurology. 2021 Apr 28. pii: WNL.0000000000012101.
PubMed

SHELLY S, Mills JR, Dubey D, McKeon A, et al
Clinical Utility of Striational Antibodies in Paraneoplastic and Myasthenia Gravis Paraneoplastic Panels.
Neurology. 2021 Apr 26. pii: WNL.0000000000012050.
PubMed Abstract available

SALAVISA M, Serrazina F, Pires P, Correia AS, et al
Teaching Video NeuroImages: Infratentorial Multiple Sclerosis Relapse Presenting as Continuous Hemifacial Myokymia.
Neurology. 2021 Apr 26. pii: WNL.0000000000012052.
PubMed

GASPERI C, Hapfelmeier A, Daltrozzo T, Schneider A, et al
Systematic Assessment of Medical Diagnoses Preceding the First Diagnosis of Multiple Sclerosis.
Neurology. 2021 Apr 26. pii: WNL.0000000000012074.
PubMed Abstract available

SOLOMON AJ, Ascherio A
Early Diagnosis of Multiple Sclerosis: Further Evidence for Missed Opportunity.
Neurology. 2021 Apr 26. pii: WNL.0000000000012087.
PubMed

Association of Gray Matter Atrophy Patterns With Clinical Phenotype and Progression in Multiple Sclerosis.
Neurology. 2021 Apr 23. pii: WNL.0000000000012021.
PubMed

EID K, Torkildsen OF, Aarseth J, Flemmen HO, et al
Perinatal Depression and Anxiety in Women with Multiple Sclerosis: A Population-Based Cohort Study.
Neurology. 2021 Apr 21. pii: WNL.0000000000012062.
PubMed Abstract available

YEH WZ, Widyastuti PA, Van der Walt A, Stankovich J, et al
Natalizumab, Fingolimod and Dimethyl Fumarate Use and Pregnancy-Related Relapse and Disability in Women With Multiple Sclerosis.
Neurology. 2021 Apr 20. pii: WNL.0000000000012084.
PubMed Abstract available

SHELLY S, Shouman K, Paul P, Engelstad J, et al
Expanding the Spectrum of Chronic Immune Sensory Polyradiculopathy: CISP-Plus.
Neurology. 2021;96:e2078-e2089.
PubMed Abstract available

NISHIDA H, Kohyama K, Kumada S, Takanashi JI, et al
Evaluation of the Diagnostic Criteria for Anti-NMDA Receptor Encephalitis in Japanese Children.
Neurology. 2021;96:e2070-e2077.
PubMed Abstract available

COLLONGUES N, Alves Do Rego C, Bourre B, Biotti D, et al
Pregnancy in Patients With AQP4-Ab, MOG-Ab, or Double-Negative Neuromyelitis Optica Disorder.
Neurology. 2021;96:e2006-e2015.
PubMed Abstract available

LAMBE J, Risher H, Filippatou AG, Murphy OC, et al
Modulation of Retinal Atrophy With Rituximab in Multiple Sclerosis.
Neurology. 2021 Apr 7. pii: WNL.0000000000011933.
PubMed Abstract available

BOURDETTE D, Killestein J
Quelling Public Fears about Guillain-Barre Syndrome and COVID-19 Vaccination.
Neurology. 2021 Apr 6. pii: WNL.0000000000011882.
PubMed

MARQUEZ LOZA AM, Holroyd KB, Johnson SA, Pilgrim DM, et al
Guillain- Barre Syndrome in the Placebo and Active Arms of a COVID-19 Vaccine Clinical Trial: Temporal Associations Do Not Imply Causality.
Neurology. 2021 Apr 6. pii: WNL.0000000000011881.
PubMed

ALLEN JA, Pasnoor M, Dimachkie MM, Ajroud-Driss S, et al
Quantifying Treatment-Related Fluctuations in CIDP: Results of the GRIPPER Study.
Neurology. 2021;96:e1876-e1886.
PubMed Abstract available

March 2021

POIRION E, Tonietto M, Lejeune FX, Ricigliano VAG, et al
Structural and Clinical Correlates of a Periventricular Gradient of Neuroinflammation in Multiple Sclerosis.
Neurology. 2021 Mar 18. pii: WNL.0000000000011700.
PubMed Abstract available

GARDIN T, Longbrake EE
Inducing or "Unmasking" Autoimmunity? The Role of Immune Checkpoint Therapy in Propagating Neurologic Immune-Related Adverse Events.
Neurology. 2021 Mar 16. pii: WNL.0000000000011812.
PubMed

LAMBE J, Fitzgerald KC, Murphy OC, Filippatou AG, et al
Association of Spectral-Domain OCT With Long-term Disability Worsening in Multiple Sclerosis.
Neurology. 2021 Mar 2. pii: WNL.0000000000011788.
PubMed Abstract available

VILLOSLADA P, Galetta SL, Toosy A
Seeing the Finish Line: Can Baseline OCT Values Predict Long-Term Disability and Therapeutic Management in Multiple Sclerosis?
Neurology. 2021 Mar 2. pii: WNL.0000000000011793.
PubMed

BANSAL P, Paul BS, Singh G
Multiple Sclerosis Relapse Presenting As Sensorineural Hearing Loss.
Neurology. 2021 Mar 2. pii: WNL.0000000000011796.
PubMed

February 2021

MUTHUSAMY K, Boyer S, Patterson M, Bierau J, et al
Neuroimaging Findings in Inosine Triphosphate Pyrophosphohydrolase (ITPase) Deficiency.
Neurology. 2021 Feb 16. pii: WNL.0000000000011719.
PubMed

KALAITZIDIS G, Calabresi PA
Is Cerebrospinal Fluid Responsible for Innate Immune Cell Activation and Neurotoxicity in Multiple Sclerosis?
Neurology. 2021 Feb 15. pii: WNL.0000000000011694.
PubMed

Evaluation of Multiple Sclerosis Disability Outcome Measures Using Pooled Clinical Trial Data.
Neurology. 2021 Feb 12. pii: WNL.0000000000011677.
PubMed

SOLE G, Mathis S, Friedman D, Salort-Campana E, et al
Impact of Coronavirus Disease 2019 in a French Cohort of Myasthenia Gravis.
Neurology. 2021 Feb 10. pii: WNL.0000000000011669.
PubMed Abstract available

ZEPHIR H, Poupart J, Deschamps R, Audoin B, et al
Author Response: Evaluation of Efficacy and Tolerability of First-Line Therapies in NMOSD.
Neurology. 2021;96:295-296.
PubMed

LEITE MI
Reader Response: Evaluation of Efficacy and Tolerability of First-Line Therapies in NMOSD.
Neurology. 2021;96:294-295.
PubMed

DALAKAS MC
Limited Benefits Halt Enrollment in Hematopoietic Stem Cell Transplantation Trial for Stiff-Person Syndrome: Should There Be More to Come?
Neurology. 2021;96:239-240.
PubMed

BURT RK, Balabanov R, Han X, Quigley K, et al
Autologous Hematopoietic Stem Cell Transplantation for Stiff-Person Spectrum Disorder: A Clinical Trial.
Neurology. 2021;96:e817-e830.
PubMed Abstract available

RIM J, Byler M, Soldatos A, Notarangelo L, et al
Opinion and Special Articles: Cerebellar Ataxia and Liver Failure Complicating IPEX Syndrome.
Neurology. 2021;96:e956-e959.
PubMed

VALLAT JM, Duchesne M, Corcia P, Richard L, et al
The Wide Spectrum of Pathophysiologic Mechanisms of Paraproteinemic Neuropathy.
Neurology. 2021;96:214-225.
PubMed Abstract available

NISHI R, Koike H, Ohyama K, Fukami Y, et al
Association Between IL-5 Levels and the Clinicopathologic Features of Eosinophilic Granulomatosis With Polyangiitis.
Neurology. 2021;96:226-229.
PubMed

January 2021

ALPING P, Burman J, Lycke J, Frisell T, et al
Safety of Alemtuzumab and Autologous Hematopoietic Stem Cell Transplantation Compared to Non-induction Therapies for Multiple Sclerosis.
Neurology. 2021 Jan 29. pii: WNL.0000000000011545.
PubMed Abstract available

BROWNLEE WJ, Galetta S
Optic Nerve in Multiple Sclerosis Diagnostic Criteria: An Aye to the Eyes?
Neurology. 2021;96:139-140.
PubMed

SORMANI MP, Tur C, Barkhof F
Ibudilast: A Paradigm Shift for Progressive Multiple Sclerosis?
Neurology. 2021;96:141-142.
PubMed

SPAGNI G, Tricoli L, Modoni A, Monforte M, et al
Clinical Reasoning: A 71-Year-Old Man Presenting With Acute Onset Dysarthria and Dysphagia.
Neurology. 2021;96:180-184.
PubMed

BOFFA G, Massacesi L, Inglese M, Mariottini A, et al
Long-Term Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis.
Neurology. 2021 Jan 20. pii: WNL.0000000000011461.
PubMed Abstract available

LEAVITT VM, Rocca M
Siponimod for Cognition in Secondary Progressive Multiple Sclerosis: Thinking Through the Evidence.
Neurology. 2021;96:91-92.
PubMed

ROCCA MA, Valsasina P, Meani A, Gobbi C, et al
Association of Gray Matter Atrophy Patterns with Clinical Phenotype and Progression in Multiple Sclerosis.
Neurology. 2021 Jan 13. pii: WNL.0000000000011494.
PubMed Abstract available

PAPP V, Magyari M, Aktas O, Berger T, et al
Worldwide Incidence and Prevalence of Neuromyelitis Optica: A Systematic Review.
Neurology. 2021;96:59-77.
PubMed Abstract available

GREEN C, Morrison H, Smith P, Golestani F, et al
Teaching Neuroimages: COVID-19-Associated Acute Disseminated Encephalomyelitis With Corpus Callosal Hemorrhage.
Neurology. 2021;96:e307-e308.
PubMed

BOVIS F, Kalincik T, Lublin F, Cutter G, et al
Treatment Response Score to Glatiramer Acetate or Interferon Beta-1a.
Neurology. 2021;96:e214-e227.
PubMed Abstract available

SHAH S, Klassen BT, Flanagan EP
Paroxysmal Dysarthria-Ataxia in Multiple Sclerosis.
Neurology. 2021 Jan 5. pii: WNL.0000000000011498.
PubMed

KALINCIK T, Sormani MP, Tur C
Has the Time Come to Revisit Our Standard Measures of Disability Progression in Multiple Sclerosis?
Neurology. 2021;96:12-13.
PubMed

December 2020

KALINCIK T, Diouf I, Sharmin S, Malpas C, et al
Effect of Disease Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years.
Neurology. 2020 Dec 28. pii: WNL.0000000000011242.
PubMed Abstract available

The 2013 clinical course descriptors for multiple sclerosis: A clarification.
Neurology. 2020 Dec 22. pii: WNL.0000000000011198.
PubMed

BENEDICT RHB, Tomic D, Cree BA, Fox R, et al
Siponimod and cognition in secondary progressive multiple sclerosis: EXPAND secondary analyses.
Neurology. 2020 Dec 16. pii: WNL.0000000000011275.
PubMed Abstract available

VIDAL-JORDANA A, Rovira A, Arrambide G, Otero-Romero S, et al
Optic nerve region in multiple sclerosis diagnosis: the utility of visual evoked potentials.
Neurology. 2020 Dec 16. pii: WNL.0000000000011339.
PubMed Abstract available

LEVISON LS, Thomsen RW, Sindrup SH, Andersen H, et al
Association of Hospital-Diagnosed Infections and Antibiotic Use with Risk of Developing Guillain-Barre Syndrome.
Neurology. 2020 Dec 14. pii: WNL.0000000000011342.
PubMed Abstract available

GRAUS F, Dalmau J
Author response: Hashimoto encephalopathy in the 21st century.
Neurology. 2020;95:1068.
PubMed

SHUBHAKARAN K
Reader response: Hashimoto encephalopathy in the 21st century.
Neurology. 2020;95:1067-1068.
PubMed

LEE MY, Yong KP, Hyun JW, Kim SH, et al
Incidence of interattack asymptomatic brain lesions in NMO spectrum disorder.
Neurology. 2020;95:e3124-e3128.
PubMed Abstract available

RUSS JB, Timbie CM, Li Y, Gonzalez-Giraldo E, et al
Clinical Reasoning: An 11-year-old girl with focal seizures, fevers, and unilateral, enhancing cortical lesions.
Neurology. 2020;95:e3153-e3159.
PubMed

TANBOON J, Inoue M, Hirakawa S, Tachimori H, et al
Pathological features of anti-Mi-2 dermatomyositis.
Neurology. 2020 Dec 4. pii: WNL.0000000000011269.
PubMed Abstract available

NISHIJIMA H, Suzuki C, Kon T, Nakamura T, et al
Bilateral Thalamic Lesions Associated with Atezolizumab-induced Autoimmune Encephalitis.
Neurology. 2020 Dec 2. pii: WNL.0000000000011297.
PubMed

NAISMITH RT, Bermel RA, Coffey CS, Goodman AD, et al
Effects of ibudilast on MRI measures in the phase 2 SPRINT-MS study.
Neurology. 2020 Dec 2. pii: WNL.0000000000011314.
PubMed Abstract available

LANGESKOV-CHRISTENSEN M, Grondahl Hvid L, Nygaard MKE, Ringgaard S, et al
Efficacy of high-intensity aerobic exercise on brain MRI measures in multiple sclerosis.
Neurology. 2020 Dec 1. pii: WNL.0000000000011241.
PubMed Abstract available

BINZER S, Manouchehrinia A, Hillert J
Author response: Disability worsening among persons with multiple sclerosis and depression: A Swedish cohort study.
Neurology. 2020;95:1026.
PubMed

BSTEH G, Berger T
Reader response: Disability worsening among persons with multiple sclerosis and depression: A Swedish cohort study.
Neurology. 2020;95:1025-1026.
PubMed

GANESH A, Galetta S
Editors' note: Disability worsening among persons with multiple sclerosis and depression: A Swedish cohort study.
Neurology. 2020;95:1025.
PubMed

SPATOLA M, Petit Pedrol M, Maudes E, Simabukuro M, et al
Clinical features, prognostic factors, and antibody effects in anti-mGluR1 encephalitis.
Neurology. 2020;95:e3012-e3025.
PubMed Abstract available

November 2020

MARRIE RA, Maxwell C, Mahar A, Ekuma O, et al
Cancer incidence and mortality rates in multiple sclerosis: A matched cohort study.
Neurology. 2020 Nov 25. pii: WNL.0000000000011219.
PubMed Abstract available

LI V, Malladi P, Simeoni S, Pakzad M, et al
A clinico-neurophysiological study of urogenital dysfunction in MOG-antibody transverse myelitis.
Neurology. 2020;95:e2924-e2934.
PubMed Abstract available

MANTEGAZZA R, Wolfe GI, Muppidi S, Wiendl H, et al
Post-intervention status in patients with refractory myasthenia gravis treated with eculizumab during REGAIN and its open-label extension.
Neurology. 2020 Nov 23. pii: WNL.0000000000011207.
PubMed Abstract available

BRIL V, Benatar M, Andersen H, Vissing J, et al
Efficacy and safety of rozanolixizumab in moderate-to-severe generalised myasthenia gravis: A phase 2 RCT.
Neurology. 2020 Nov 20. pii: WNL.0000000000011108.
PubMed Abstract available

FEIBEL RM
Henry R. Viets, MD, and the history of myasthenia gravis.
Neurology. 2020 Nov 20. pii: WNL.0000000000011239.
PubMed Abstract available

NARAYANASWAMI P, Sanders DB, Wolfe G, Benatar M, et al
International consensus guidance for management of myasthenia gravis: 2020 update.
Neurology. 2020 Nov 3. pii: WNL.0000000000011124.
PubMed Abstract available

HOANG P, Hurtubise B, Muppidi S
Clinical Reasoning: Therapeutic considerations in myasthenic crisis due to COVID-19 infection.
Neurology. 2020;95:840-843.
PubMed

October 2020

KOCH MW, Mostert J, Repovic P, Bowen JD, et al
Reliability of outcome measures in clinical trials in secondary progressive multiple sclerosis.
Neurology. 2020 Oct 26. pii: WNL.0000000000011123.
PubMed Abstract available

KLEIN DA COSTA B, Brant de Souza Melo R, Passos GRD, Gomes Meneses Sevilha Castro D, et al
Unraveling B lymphocytes in CNS inflammatory diseases: Distinct mechanisms and treatment targets.
Neurology. 2020;95:733-744.
PubMed Abstract available

MASTRANGELO V, Asioli GM, Foschi M, Padroni M, et al
Bilateral extensive corticospinal tract lesions in MOG antibody-associated disease.
Neurology. 2020;95:648-649.
PubMed

FELIPE-RUCIAN A, Wegener-Panzer A, Nassenstein I, Reindl M, et al
Teaching NeuroImages: Bilateral optic neuritis: When to suspect anti-MOG antibodies.
Neurology. 2020;95:e2045-e2046.
PubMed

September 2020

RINGELSTEIN M, Harmel J, Zimmermann H, Brandt AU, et al
Author response: Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disorders.
Neurology. 2020;95:610.
PubMed

CHEN JJ
Reader response: Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disorders.
Neurology. 2020;95:609-610.
PubMed

GIANNOCCARO MP, Paolucci M, Zenesini C, Di Stasi V, et al
Comparison of ice pack test and single-fiber EMG diagnostic accuracy in patients referred for myasthenic ptosis.
Neurology. 2020;95:e1800-e1806.
PubMed Abstract available

Reversibility of the effects of natalizumab on peripheral immune cell dynamics in MS patients.
Neurology. 2020 Sep 16. pii: WNL.0000000000008927.
PubMed

MOCCIA M, van de Pavert S, Eshaghi A, Haider L, et al
Pathological correlates of the magnetization transfer ratio in multiple sclerosis.
Neurology. 2020 Sep 16. pii: WNL.0000000000010909.
PubMed Abstract available

SHELLY S, Paul P, Bi H, Dubey D, et al
Improving accuracy of myasthenia gravis autoantibody testing by reflex algorithm.
Neurology. 2020 Sep 16. pii: WNL.0000000000010910.
PubMed Abstract available

ROTSTEIN DL, Yeh EA
Could wider social networks prevent disability in MS and other neurologic disorders?
Neurology. 2020;95:463-464.
PubMed

LIBERATORE G, De Santis T, Doneddu PE, Gentile F, et al
Clinical Reasoning: A case of COVID-19 associated pharyngeal-cervical-brachial variant of Guillain-Barre syndrome.
Neurology. 2020 Sep 11. pii: WNL.0000000000010817.
PubMed

KULICK-SOPER CV, McKee JL, Wolf RL, Mohan S, et al
Pearls & Oy-sters: Bilateral globus pallidus lesions in a patient with COVID-19.
Neurology. 2020;95:454-457.
PubMed

VIRHAMMAR J, Kumlien E, Fallmar D, Frithiof R, et al
Acute necrotizing encephalopathy with SARS-CoV-2 RNA confirmed in cerebrospinal fluid.
Neurology. 2020;95:445-449.
PubMed Abstract available

BENITO-LEON J, Mendez-Guerrero A, Gutierrez-Ortiz C
Author response: Miller Fisher syndrome and polyneuritis cranialis in COVID-19.
Neurology. 2020;95:409.
PubMed

NI J, Xu X
Reader response: Miller Fisher syndrome and polyneuritis cranialis in COVID-19.
Neurology. 2020;95:408-409.
PubMed

SIEGLER JE 3RD, Galetta S
Editors' note: Miller Fisher syndrome and polyneuritis cranialis in COVID-19.
Neurology. 2020;95:408.
PubMed

SEESE RR, Guillen D, Gaesser JM, Abdel-Hamid HZ, et al
Clinical Reasoning: A 14-year-old boy with acute weakness, paresthesias, and headache.
Neurology. 2020;95:e1285-e1289.
PubMed

KWON YN, Jung JH, Kim SJ, Sung JJ, et al
Progressive brain atrophy and white matter changes in MOG encephalomyelitis.
Neurology. 2020;95:402-403.
PubMed

August 2020

BENITO-LEON J, Mendez-Guerrero A, Gutierrez-Ortiz C
Author response: Miller Fisher syndrome and polyneuritis cranialis in COVID-19.
Neurology. 2020;95:370.
PubMed

VAVOUGIOS GD
Reader response: Miller Fisher syndrome and polyneuritis cranialis in COVID-19.
Neurology. 2020;95:369.
PubMed

VAIRA LA, Salzano G, De Riu G
Reader response: Miller Fisher syndrome and polyneuritis cranialis in COVID-19.
Neurology. 2020;95:368-369.
PubMed

LEWIS A, Galetta S
Editors' note: Miller Fisher syndrome and polyneuritis cranialis in COVID-19.
Neurology. 2020;95:368.
PubMed

WALLIN MT
Initial highly effective therapy for MS: A strong start.
Neurology. 2020;95:e1114-e1116.
PubMed

SECHI E, Markovic SN, McKeon A, Dubey D, et al
Neurological autoimmunity and immune checkpoint inhibitors: Autoantibody profiles and outcomes.
Neurology. 2020 Aug 13. pii: WNL.0000000000010632.
PubMed Abstract available

DOUGHTY CT, Guidon AC
Stronger together: Diagnostic testing for ocular myasthenia gravis.
Neurology. 2020 Aug 11. pii: WNL.0000000000010616.
PubMed

RUPRECHT K, Pfuhl C, Oechtering J
Author response: Intrathecal IgM production is a strong risk factor for early conversion to multiple sclerosis.
Neurology. 2020;95:277-278.
PubMed

ALCALA C, Perez-Miralles FC, Gil-Perotin S, Casanova B, et al
Reader response: Intrathecal IgM production is a strong risk factor for early conversion to multiple sclerosis.
Neurology. 2020;95:277.
PubMed

SIEGLER JE 3RD, Galetta S
Editors' note: Intrathecal IgM production is a strong risk factor for early conversion to multiple sclerosis.
Neurology. 2020;95:276.
PubMed

OUTTERYCK O, Lopes R, Drumez E, Labreuche J, et al
Optical coherence tomography for detection of asymptomatic optic nerve lesions in clinically isolated syndrome.
Neurology. 2020;95:e733-e744.
PubMed Abstract available

VAN KEMPEN ZLE, Hoogervorst ELJ, Wattjes MP, Kalkers NF, et al
Personalized extended interval dosing of natalizumab in MS: A prospective multicenter trial.
Neurology. 2020;95:e745-e754.
PubMed Abstract available

DIXON L, Shah S
Teaching NeuroImages: Hypertrophic polyneuropathy.
Neurology. 2020;95:e779-e780.
PubMed

LEE I, Kuo HC, Aban IB, Cutter GR, et al
Minimal manifestation status and prednisone withdrawal in the MGTX trial.
Neurology. 2020;95:e755-e766.
PubMed Abstract available

ARINO H, Munoz-Lopetegi A, Martinez-Hernandez E, Armangue T, et al
Sleep disorders in anti-NMDAR encephalitis.
Neurology. 2020;95:e671-e684.
PubMed Abstract available

LEVIN SN, Riley CS, Dhand A, White CC, et al
Association of Social Network Structure and Physical Function in Patients With Multiple Sclerosis.
Neurology. 2020 Aug 7. pii: WNL.0000000000010460.
PubMed Abstract available

MENDOZA M, Tran C, Bril V, Katzberg HD, et al
Patient-acceptable symptom states in myasthenia gravis.
Neurology. 2020 Aug 5. pii: WNL.0000000000010574.
PubMed Abstract available

PIEHL F, Wolfe GI
Is the treatment of myasthenia gravis improving? Why not ask our patients?
Neurology. 2020 Aug 5. pii: WNL.0000000000010578.
PubMed

DINKIN M, Gao V, Kahan J, Bobker S, et al
COVID-19 presenting with ophthalmoparesis from cranial nerve palsy.
Neurology. 2020;95:221-223.
PubMed

GUTIERREZ-ORTIZ C, Mendez-Guerrero A, Rodrigo-Rey S, San Pedro-Murillo E, et al
Miller Fisher syndrome and polyneuritis cranialis in COVID-19.
Neurology. 2020;95:e601-e605.
PubMed Abstract available

NELSON LM, Bourdette D
Two decades of research: Time to incorporate comorbidity management into the care of MS?
Neurology. 2020;95:193-194.
PubMed

SALTER A, Kowalec K, Fitzgerald KC, Cutter G, et al
Comorbidity is associated with disease activity in MS: Findings from the CombiRx trial.
Neurology. 2020;95:e446-e456.
PubMed Abstract available

BOSE G, Fitzpatrick T, Yogendrakumar V, Zwicker JC, et al
Clinical Reasoning: A 73-year-old man with recurrent aphasia, headaches and confusion.
Neurology. 2020 Aug 4. pii: WNL.0000000000010475.
PubMed

July 2020

KILLESTEIN J, Du Pasquier R, Hemmer B
Vaccination in B-cell depleted MS patients.
Neurology. 2020 Jul 29. pii: WNL.0000000000010378.
PubMed

BAR-OR A, Calkwood JC, Chognot C, Evershed J, et al
Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: The VELOCE study.
Neurology. 2020 Jul 29. pii: WNL.0000000000010380.
PubMed Abstract available

VILLOSLADA P, Sanchez-Dalmau B, Galetta S
Optical coherence tomography: A useful tool for identifying subclinical optic neuropathy in diagnosing multiple sclerosis.
Neurology. 2020 Jul 28. pii: WNL.0000000000009840.
PubMed

HAUSER SL, Kappos L, Arnold DL, Bar-Or A, et al
Five-years of ocrelizumab in relapsing multiple sclerosis: OPERA studies open-label extension.
Neurology. 2020 Jul 20. pii: WNL.0000000000010376.
PubMed Abstract available

SANTORO JD, Waltz M, Aaen G, Belman A, et al
Pediatric Multiple Sclerosis Severity Score in a Large U.S. Cohort.
Neurology. 2020 Jul 20. pii: WNL.0000000000010414.
PubMed Abstract available

KAPOOR R, Smith KE, Allegretta M, Arnold DL, et al
Serum neurofilament light as a biomarker in progressive multiple sclerosis.
Neurology. 2020 Jul 16. pii: WNL.0000000000010346.
PubMed Abstract available

HERRAETS IJT, Goedee HS, Telleman JA, van Eijk RPA, et al
Nerve ultrasound for diagnosing chronic inflammatory neuropathy: a multicenter validation study.
Neurology. 2020 Jul 16. pii: WNL.0000000000010369.
PubMed Abstract available

HERMAN C, Mayer K, Sarwal A
Scoping review of prevalence of neurologic comorbidities in patients hospitalized for COVID-19.
Neurology. 2020;95:77-84.
PubMed Abstract available

CHEN JJ, Flanagan EP, Bhatti MT, Jitprapaikulsan J, et al
Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder.
Neurology. 2020;95:e111-e120.
PubMed Abstract available

MANISCALCO GT, Mariotto S, Hoftberger R, Capra R, et al
GABAA receptor autoimmunity after alemtuzumab treatment for multiple sclerosis.
Neurology. 2020 Jul 10. pii: WNL.0000000000010310.
PubMed

GIOVANNONI G, Knappertz V, Steinerman JR, Tansy AP, et al
A randomized, placebo-controlled phase 2 trial of laquinimod in primary progressive multiple sclerosis.
Neurology. 2020 Jul 10. pii: WNL.0000000000010284.
PubMed Abstract available

FERREIRA D, Ferro D, Bastos G, Pinto M, et al
Teaching NeuroImages: Useless (and restless) hand of Oppenheim in multiple sclerosis.
Neurology. 2020 Jul 9. pii: WNL.0000000000010261.
PubMed

TOMSCHIK M, Hilger E, Rath J, Mayer EM, et al
Subgroup Stratification and Outcome in Recently Diagnosed Generalized Myasthenia Gravis.
Neurology. 2020 Jul 8. pii: WNL.0000000000010209.
PubMed Abstract available

BURON MD, Chalmer TA, Sellebjerg F, Barzinji I, et al
Initial high-efficacy disease-modifying therapy in multiple sclerosis: A nationwide cohort study.
Neurology. 2020 Jul 7. pii: WNL.0000000000010135.
PubMed Abstract available

June 2020

PONCIANO A, Carvalho JN, Gala D, Leite J, et al
Pearls & Oy-sters: Guillain-Barre syndrome: An unusual presentation of acute intermittent porphyria.
Neurology. 2020 Jun 19. pii: WNL.0000000000009838.
PubMed

RUITER AM, Naber WC, Tannemaat MR, Verschuuren JJGM, et al
The face of myasthenia gravis.
Neurology. 2020 Jun 10. pii: WNL.0000000000009782.
PubMed

JONSSON DI, Sveinsson O, Hakim R, Brundin L, et al
Author response: Epidemiology of NMOSD in Sweden from 1987 to 2013: A nationwide population-based study.
Neurology. 2020;94:1049-1050.
PubMed

PAPP V, Petersen T, Magyari M, Koch-Henriksen N, et al
Reader response: Epidemiology of NMOSD in Sweden from 1987 to 2013: A nationwide population-based study.
Neurology. 2020;94:1048-1049.
PubMed

VAN KEMPEN ZLE, Kryscio RJ, Dalla Costa G
Serum neurofilament light as a prognostic marker for MS disability: Are we there yet?
Neurology. 2020;94:1013-1014.
PubMed

DAVION JB, Lopes R, Drumez E, Labreuche J, et al
Asymptomatic optic nerve lesions: An underestimated cause of silent retinal atrophy in MS.
Neurology. 2020;94:e2468-e2478.
PubMed Abstract available

BIRCA V, Saint-Martin C, Myers KA
Teaching Video NeuroImages: Pathologic yawning: A sign of brainstem involvement in acute disseminated encephalomyelitis?
Neurology. 2020;94:e2497-e2498.
PubMed

COSTELLO F, Dalakas MC
Cranial Neuropathies and COVID-19: Neurotropism and Autoimmunity.
Neurology. 2020 Jun 2. pii: WNL.0000000000009921.
PubMed Abstract available

ALLENBACH Y, Uzunhan Y, Toquet S, Leroux G, et al
Different phenotypes in dermatomyositis associated with anti-MDA5 antibody: Study of 121 cases.
Neurology. 2020 Jun 2. pii: WNL.0000000000009727.
PubMed Abstract available

GUIDON AC, Amato AA
COVID-19 and neuromuscular disorders.
Neurology. 2020;94:959-969.
PubMed Abstract available

MARRIE RA, Leavitt VM
Disease-modifying therapies as cognition-modifying therapies? Treating cognitive impairment in MS.
Neurology. 2020;94:957-958.
PubMed

MARTINEZ-HERNANDEZ E, Guasp M, Garcia-Serra A, Maudes E, et al
Clinical significance of anti-NMDAR concurrent with glial or neuronal surface antibodies.
Neurology. 2020;94:e2302-e2310.
PubMed Abstract available

CORREALE J, Marrodan M, Benarroch EE
What is the role of axonal ion channels in multiple sclerosis?
Neurology. 2020 Jun 1. pii: WNL.0000000000009754.
PubMed

May 2020

LUBLIN FD, Coetzee T, Cohen JA, Marrie RA, et al
The 2013 clinical course descriptors for multiple sclerosis: A clarification.
Neurology. 2020 May 29. pii: WNL.0000000000009636.
PubMed Abstract available

RAFAY MF, Shapiro KA, Surmava AM, deVeber GA, et al
Spectrum of cerebral arteriopathies in children with arterial ischemic stroke.
Neurology. 2020 May 26. pii: WNL.0000000000009557.
PubMed Abstract available

MANOUCHEHRINIA A, Stridh P, Khademi M, Leppert D, et al
Plasma neurofilament light levels are associated with the risk of disability in multiple sclerosis.
Neurology. 2020 May 20. pii: WNL.0000000000009571.
PubMed Abstract available

LANDMEYER NC, Burkner PC, Wiendl H, Ruck T, et al
Disease-modifying treatments and cognition in relapsing-remitting multiple sclerosis: A meta-analysis.
Neurology. 2020 May 19. pii: WNL.0000000000009522.
PubMed Abstract available

LAMBE J, Rothman A, Prince J, Saidha S, et al
Retinal pathology occurs in stiff-person syndrome.
Neurology. 2020;94:e2126-e2131.
PubMed Abstract available

DALE RC, Rostasy K
Autoimmune pediatric neuropsychiatric symptoms with pain and hypertension: CASPR2 antibody.
Neurology. 2020 May 18. pii: WNL.0000000000009521.
PubMed

SYRBE S, Stettner GM, Bally J, Borggraefe I, et al
CASPR2 autoimmunity in children expanding to mild encephalopathy with hypertension.
Neurology. 2020 May 18. pii: WNL.0000000000009523.
PubMed Abstract available

MATHIS S, Soulages A, Le Masson G, Vallat JM, et al
History of acute polyradiculoneuropathy (part 2): From 1916 to 2019.
Neurology. 2020;94:836-840.
PubMed Abstract available

VAN OMMEREN R, Izenberg A, Shadowitz S, Aviv R, et al
Clinical Reasoning: An 81-year-old woman with decreased consciousness and fluctuating right facial droop.
Neurology. 2020;94:843-848.
PubMed

CORTESE M, Munger KL, Martinez-Lapiscina EH, Barro C, et al
Vitamin D, smoking, EBV, and long-term cognitive performance in MS: 11-year follow-up of BENEFIT.
Neurology. 2020;94:e1950-e1960.
PubMed Abstract available

GADOT R, Nascimento FA, Mims M, Nunez-Wallace K, et al
Clinical Reasoning: A 59-year-old woman with multiple myeloma and lower extremity weakness and numbness.
Neurology. 2020;94:794-800.
PubMed

April 2020

ARUN T, Pattison L, Palace J
Distinguishing neurosarcoidosis from multiple sclerosis based on CSF analysis: A retrospective cohort study.
Neurology. 2020 Apr 30. pii: WNL.0000000000009491.
PubMed Abstract available

MATHIS S, Soulages A, Vallat JM, Le Masson G, et al
History of acute polyradiculoneuropathy (part 1): The prehistory of Guillain-Barre syndrome.
Neurology. 2020 Apr 28. pii: WNL.0000000000009401.
PubMed Abstract available

KIM HW, Lamb C, Jamali S, Lopez Chiriboga AS, et al
Mystery Case: Anti-NMDAR encephalitis with overlapping demyelinating syndrome.
Neurology. 2020;94:e1866-e1869.
PubMed

NISHI R, Koike H, Ohyama K, Fukami Y, et al
Differential clinicopathologic features of EGPA-associated neuropathy with and without ANCA.
Neurology. 2020;94:e1726-e1737.
PubMed Abstract available

POUPART J, Giovannelli J, Deschamps R, Audoin B, et al
Evaluation of efficacy and tolerability of first-line therapies in NMOSD.
Neurology. 2020;94:e1645-e1656.
PubMed Abstract available

HUSSEIN O, Jordan Z, Abd Elazim A, Stino A, et al
Pearls & Oy-sters: Rapid progression of prion disease associated with transverse myelitis: A rare presentation.
Neurology. 2020;94:e1670-e1672.
PubMed

LANGER-GOULD A, Smith JB, Albers KB, Xiang AH, et al
Pregnancy-related relapses and breastfeeding in a contemporary multiple sclerosis cohort.
Neurology. 2020 Apr 13. pii: WNL.0000000000009374.
PubMed Abstract available

DOBSON R, Mowry EM
Breastfeeding may reduce postpartum relapse in some women with multiple sclerosis.
Neurology. 2020 Apr 13. pii: WNL.0000000000009369.
PubMed

MEALY MA, Kozachik SL, Cook LJ, Totonis L, et al
Scrambler therapy improves pain in neuromyelitis optica: A randomized controlled trial.
Neurology. 2020 Apr 8. pii: WNL.0000000000009370.
PubMed Abstract available

LEAVITT VM
Neurologic determinism? Key update to an age-old debate.
Neurology. 2020;94:605-606.
PubMed

BROWNLEE W, Bourdette D, Broadley S, Killestein J, et al
Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic.
Neurology. 2020 Apr 2. pii: WNL.0000000000009507.
PubMed Abstract available

March 2020

CARVALHO NETO EG, Gomes MF, Dos Santos IP, Monteiro MD, et al
Teaching Video NeuroImages: Useful bedside testing for myasthenia gravis: The phenomenon of enhanced ptosis.
Neurology. 2020 Mar 31. pii: WNL.0000000000009238.
PubMed

DE MEEL RHP, Keene KR, Wirth MA, Weber KP, et al
Repetitive ocular vestibular evoked myogenic potentials in myasthenia gravis.
Neurology. 2020 Mar 26. pii: WNL.0000000000009306.
PubMed Abstract available

GRONSETH GS, Barohn R, Narayanaswami P
Practice advisory: Thymectomy for myasthenia gravis (practice parameter update): Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Neurology. 2020 Mar 25. pii: WNL.0000000000009294.
PubMed Abstract available

ARGYROPOULOS GPD, Moore L, Loane C, Roca-Fernandez A, et al
Pathologic tearfulness after limbic encephalitis: A novel disorder and its neural basis.
Neurology. 2020;94:e1320-e1335.
PubMed Abstract available

YEH EA, Sormani MP
Tracking therapies in MS: More evidence in favor of neurofilament.
Neurology. 2020;94:465-466.
PubMed

TINTORE M, Perez-Hoyos S, Otero-Romero S
Author response: Menarche, pregnancies, and breastfeeding do not modify long-term prognosis in multiple sclerosis.
Neurology. 2020;94:456-457.
PubMed

JOKUBAITIS VG, Dobson R
Reader response: Menarche, pregnancies, and breastfeeding do not modify long-term prognosis in multiple sclerosis.
Neurology. 2020;94:455-456.
PubMed

GANESH A, Galetta S
Editors' note: Menarche, pregnancies, and breastfeeding do not modify long-term prognosis in multiple sclerosis.
Neurology. 2020;94:455.
PubMed

AMEZCUA L, Smith JB, Gonzales EG, Haraszti S, et al
Race, ethnicity, and cognition in persons newly diagnosed with multiple sclerosis.
Neurology. 2020 Mar 9. pii: WNL.0000000000009210.
PubMed Abstract available

RICE J, Woltjer R, Stienstra N, Sun E, et al
Pearls & Oy-sters: Primary angiitis of the CNS presenting with recurrent intracranial hemorrhage.
Neurology. 2020;94:e992-e995.
PubMed

Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks: Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks.
Neurology. 2020 Mar 2. pii: WNL.0000000000008670.
PubMed

February 2020

OBEIDAT AZ, Jassam YN, Hua LH, Cutter G, et al
Education Research: Multiple sclerosis and neuroimmunology fellowship training status in the United States.
Neurology. 2020 Feb 27. pii: WNL.0000000000009096.
PubMed Abstract available

BRANDSTADTER R, Ayeni O, Krieger SC, Harel NY, et al
Detection of subtle gait disturbance and future fall risk in early multiple sclerosis.
Neurology. 2020 Feb 26. pii: WNL.0000000000008938.
PubMed Abstract available

FRONTZEK K, Carta M, Losa M, Epskamp M, et al
Autoantibodies against the prion protein in individuals with PRNP mutations.
Neurology. 2020 Feb 25. pii: WNL.0000000000009183.
PubMed Abstract available

GRAVE C, Boucheron P, Rudant J, Mikaeloff Y, et al
Seasonal influenza vaccine and Guillain-Barre syndrome: A self-controlled case series study.
Neurology. 2020 Feb 25. pii: WNL.0000000000009180.
PubMed Abstract available

CORTES-VICENTE E, Alvarez-Velasco R, Segovia S, Paradas C, et al
Clinical and therapeutic features of myasthenia gravis in adults based on age at onset.
Neurology. 2020 Feb 18. pii: WNL.0000000000008903.
PubMed Abstract available

DELCOIGNE B, Manouchehrinia A, Barro C, Benkert P, et al
Blood neurofilament light levels segregate treatment effects in multiple sclerosis.
Neurology. 2020 Feb 11. pii: WNL.0000000000009097.
PubMed Abstract available

MACARON G, Willis MA, Ontaneda D, Fernandez H, et al
Palatal myoclonus, abnormal eye movements, and olivary hypertrophy in GAD65-related disorder.
Neurology. 2020;94:273-275.
PubMed

KAPOOR M, Spillane J, Englezou C, Sarri-Gonzalez S, et al
Thromboembolic risk with IVIg: Incidence and risk factors in patients with inflammatory neuropathy.
Neurology. 2020;94:e635-e638.
PubMed Abstract available

LIPKA AF, Boldingh MI, van Zwet EW, Schreurs MWJ, et al
Long-term follow-up, quality of life, and survival of patients with Lambert-Eaton myasthenic syndrome.
Neurology. 2020;94:e511-e520.
PubMed Abstract available

January 2020

RINGELSTEIN M, Harmel J, Zimmermann H, Brandt AU, et al
Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disorders.
Neurology. 2020;94:e407-e418.
PubMed Abstract available

NEUMANN B, Angstwurm K, Mergenthaler P, Kohler S, et al
Myasthenic crisis demanding mechanical ventilation: A multicenter analysis of 250 cases.
Neurology. 2020;94:e299-e313.
PubMed Abstract available

HERRAETS IJT, Goedee HS, Telleman JA, van Eijk RPA, et al
Nerve ultrasound improves detection of treatment-responsive chronic inflammatory neuropathies.
Neurology. 2020 Jan 20. pii: WNL.0000000000008978.
PubMed Abstract available

HARTUNG DM, Johnston KA, Geddes J, Bourdette DN, et al
Effect of generic glatiramer acetate on spending and use of drugs for multiple sclerosis.
Neurology. 2020 Jan 15. pii: WNL.0000000000008936.
PubMed Abstract available

KUNCHOK A, Krecke KN, Flanagan EP, Jitprapaikulsan J, et al
Does area postrema syndrome occur in myelin oligodendrocyte glycoprotein-IgG-associated disorders (MOGAD)?
Neurology. 2020;94:85-88.
PubMed

HARDING K, Zhu F, Alotaibi M, Duggan T, et al
Multiple cause of death analysis in multiple sclerosis: A population-based study.
Neurology. 2020 Jan 13. pii: WNL.0000000000008907.
PubMed Abstract available

MARRIE RA, O'Mahony J, Maxwell C, Ling V, et al
Increased mental health care use by mothers of children with multiple sclerosis.
Neurology. 2020 Jan 9. pii: WNL.0000000000008871.
PubMed Abstract available

December 2019

ZALOUM A, Falet JR, Elkrief A, Chalk C, et al
Myasthenia gravis following dabrafenib and trametinib for metastatic melanoma.
Neurology. 2019 Dec 30. pii: WNL.0000000000008860.
PubMed

MATTOZZI S, Sabater L, Escudero D, Arino H, et al
Hashimoto encephalopathy in the 21st century.
Neurology. 2019 Dec 27. pii: WNL.0000000000008785.
PubMed Abstract available

TYLER KL, Ruegg S
The neuromythology of Hashimoto encephalopathy: The emperor has no clothes.
Neurology. 2019 Dec 27. pii: WNL.0000000000008776.
PubMed

OUDEMAN J, Eftimov F, Strijkers GJ, Schneiders JJ, et al
Diagnostic accuracy of MRI and ultrasound in chronic immune-mediated neuropathies.
Neurology. 2019 Dec 11. pii: WNL.0000000000008697.
PubMed Abstract available

ROTSTEIN DL, Marrie RA, Maxwell C, Gandhi S, et al
MS risk in immigrants in the McDonald era: A population-based study in Ontario, Canada.
Neurology. 2019;93:e2203-e2215.
PubMed Abstract available

November 2019

LEE PKJ, Small JE, Vytopil M
Teaching NeuroImages: Autoimmune glial fibrillary acidic protein meningoencephalomyelitis.
Neurology. 2019;93:e2076-e2077.
PubMed

SAVRANSKY A, Rubstein A, Rios MH, Vergel SL, et al
Prognostic indicators of improvement with therapeutic plasma exchange in pediatric demyelination.
Neurology. 2019;93:e2065-e2073.
PubMed Abstract available

M HARTUNG D, Alley L, A Johnston K, Bourdette DN, et al
Qualitative study on the price of drugs for multiple sclerosis: Gaming the system.
Neurology. 2019 Nov 25. pii: WNL.0000000000008653.
PubMed Abstract available

TORABI T, Huttner A, Nowak RJ, Roy B, et al
Clinical Reasoning: Progressive proximal weakness in a 56-year-old man with bone pain.
Neurology. 2019;93:939-944.
PubMed

MCKAY KA, Ernstsson O, Manouchehrinia A, Olsson T, et al
Determinants of quality of life in pediatric- and adult-onset multiple sclerosis.
Neurology. 2019 Nov 15. pii: WNL.0000000000008667.
PubMed Abstract available

SHAN W, Liu X, Wang Q
Teaching NeuroImages: (18)F-FDG-PET/SPM analysis in 3 different stages from a patient with LGI-1 autoimmune encephalitis.
Neurology. 2019;93:e1917-e1918.
PubMed

WATERS P, Vincent A
Myelin oligodendrocyte glycoprotein CSF testing needs testing.
Neurology. 2019;93:871-872.
PubMed

MARIOTTO S, Gajofatto A, Batzu L, Delogu R, et al
Relevance of antibodies to myelin oligodendrocyte glycoprotein in CSF of seronegative cases.
Neurology. 2019;93:e1867-e1872.
PubMed Abstract available

ROCCA MA, Valsasina P, Meani A, Gobbi C, et al
Clinically relevant cranio-caudal patterns of cervical cord atrophy evolution in MS.
Neurology. 2019;93:e1852-e1866.
PubMed Abstract available

HUPPERTS R, Smolders J, Vieth R, Holmoy T, et al
Randomized trial of daily high-dose vitamin D3 in patients with RRMS receiving subcutaneous interferon beta-1a.
Neurology. 2019;93:e1906-e1916.
PubMed Abstract available

BINZER S, McKay KA, Brenner P, Hillert J, et al
Disability worsening among persons with multiple sclerosis and depression: A Swedish cohort study.
Neurology. 2019 Nov 8. pii: WNL.0000000000008617.
PubMed Abstract available

October 2019

RUDANT J, Dupont A, Mikaeloff Y, Bolgert F, et al
Author response: Surgery and risk of Guillain-Barre syndrome: A French nationwide epidemiologic study.
Neurology. 2019;93:818.
PubMed

STEINER I
Reader response: Surgery and risk of Guillain-Barre syndrome: A French nationwide epidemiologic study.
Neurology. 2019;93:817-818.
PubMed

SIEGLER JE 3RD, Galetta S
Editors' note: Surgery and risk of Guillain-Barre syndrome: A French nationwide epidemiologic study.
Neurology. 2019;93:817.
PubMed

MURARO PA, Cohen JA
Complex intensive treatment shows promise against a complex aggressive disease.
Neurology. 2019;93:776-777.
PubMed

YAO MS, Chen S, Liu J
Mystery Case: Cowden syndrome presenting with paraneoplastic encephalitis.
Neurology. 2019;93:814-816.
PubMed

MATHIS S, Le Masson G, Vallat JM
Early clinicopathologic description of nodoparanodopathy in the 19th century.
Neurology. 2019;93:788-792.
PubMed Abstract available

BURT RK, Balabanov R, Han X, Burns C, et al
Autologous nonmyeloablative hematopoietic stem cell transplantation for neuromyelitis optica.
Neurology. 2019;93:e1732-e1741.
PubMed Abstract available

VEENHUIZEN Y, Cup EHC, Jonker MA, Voet NBM, et al
Self-management program improves participation in patients with neuromuscular disease: A randomized controlled trial.
Neurology. 2019;93:e1720-e1731.
PubMed Abstract available

SORMANI MP, Naismith RT
Measuring disability in multiple sclerosis: Walking plus much more.
Neurology. 2019 Oct 22. pii: WNL.0000000000008515.
PubMed

GOLDMAN MD, LaRocca NG, Rudick RA, Hudson LD, et al
Evaluation of multiple sclerosis disability outcome measures using pooled clinical trial data.
Neurology. 2019 Oct 22. pii: WNL.0000000000008519.
PubMed Abstract available

Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Neurology. 2019;93:769.
PubMed

RAE-GRANT AD
Author response: Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Neurology. 2019;93:765.
PubMed

TRAN KR
Reader response: Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Neurology. 2019;93:764-765.
PubMed

GANESH A, Galetta S
Editors' note: Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Neurology. 2019;93:764.
PubMed

VAN KEMPEN ZLE, Doesburg D, Dekker I, Lissenberg-Witte BI, et al
The natalizumab wearing-off effect: End of natalizumab cycle, recurrence of MS symptoms.
Neurology. 2019;93:e1579-e1586.
PubMed Abstract available

DUBEY D, Jitprapaikulsan J, Bi H, Do Campo RV, et al
Amphiphysin-IgG autoimmune neuropathy: A recognizable clinicopathologic syndrome.
Neurology. 2019 Oct 17. pii: WNL.0000000000008472.
PubMed Abstract available

PAPP V, Illes Z, Magyari M, Koch-Henriksen N, et al
Author response: Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in Denmark.
Neurology. 2019;93:723.
PubMed

ASGARI N, Flanagan EP
Reader response: Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in Denmark.
Neurology. 2019;93:722-723.
PubMed

PINAL-FERNANDEZ I, Mecoli CA, Casal-Dominguez M, Pak K, et al
More prominent muscle involvement in patients with dermatomyositis with anti-Mi2 autoantibodies.
Neurology. 2019 Oct 8. pii: WNL.0000000000008443.
PubMed Abstract available

CLIFFORD DB, Tyler KL
Dosing interval of natalizumab in MS: Do good things come to those who wait?
Neurology. 2019;93:655-656.
PubMed

RYERSON LZ, Foley J, Chang I, Kister I, et al
Risk of natalizumab-associated PML in patients with MS is reduced with extended interval dosing.
Neurology. 2019;93:e1452-e1462.
PubMed Abstract available

TUR C, Kalincik T, Oh J, Sormani MP, et al
Head-to-head drug comparisons in multiple sclerosis: Urgent action needed.
Neurology. 2019 Oct 7. pii: WNL.0000000000008319.
PubMed Abstract available

September 2019

WATANABE M, Nakamura Y, Michalak Z, Isobe N, et al
Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD.
Neurology. 2019;93:e1299-e1311.
PubMed Abstract available

PFUHL C, Grittner U, Giess RM, Scheel M, et al
Intrathecal IgM production is a strong risk factor for early conversion to multiple sclerosis.
Neurology. 2019 Sep 9. pii: WNL.0000000000008237.
PubMed Abstract available

EIJLERS AJC, Dekker I, Steenwijk MD, Meijer KA, et al
Cortical atrophy accelerates as cognitive decline worsens in multiple sclerosis.
Neurology. 2019 Sep 4. pii: WNL.0000000000008198.
PubMed Abstract available

BARKHOF F, Kappos L, Wolinsky JS, Li DKB, et al
Onset of clinical and MRI efficacy of ocrelizumab in relapsing multiple sclerosis.
Neurology. 2019 Sep 4. pii: WNL.0000000000008189.
PubMed Abstract available

CAMMAERT LA, Macleod AD, Mackay GA, Duncan CW, et al
Reversible tongue atrophy in Lambert-Eaton myasthenic syndrome.
Neurology. 2019;93:459-460.
PubMed

WONG YYM, Bruijstens AL, Barro C, Michalak Z, et al
Serum neurofilament light chain in pediatric MS and other acquired demyelinating syndromes.
Neurology. 2019;93:e968-e974.
PubMed Abstract available

August 2019

Autoimmune gait disturbance accompanying adaptor protein-3B2-IgG.
Neurology. 2019 Aug 29. pii: WNL.0000000000008232.
PubMed

FAREZ MF, Correale J, Armstrong MJ, Rae-Grant A, et al
Practice guideline update summary: Vaccine-preventable infections and immunization in multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Neurology. 2019 Aug 28. pii: WNL.0000000000008157.
PubMed Abstract available

YEH EA, Graves J
Vaccination: Not a trigger for MS.
Neurology. 2019;93:377-378.
PubMed

LAW LY, Riminton DS, Nguyen M, Barnett MH, et al
The spectrum of immune-mediated and inflammatory lesions of the brainstem: Clues to diagnosis.
Neurology. 2019;93:390-405.
PubMed Abstract available

SUMOWSKI JF, Muhlert N
Dalfampridine improves slowed processing speed in MS: Picking up the pace.
Neurology. 2019;93:325-326.
PubMed

MADIGAN NN, Liewluck T, Milone M, Naddaf E, et al
Necrotizing autoimmune myopathy with tubular aggregates.
Neurology. 2019;93:313-314.
PubMed

SECHI E, Keegan BM, Kaufmann TJ, Kantarci OH, et al
Unilateral motor progression in MS: Association with a critical corticospinal tract lesion.
Neurology. 2019;93:e628-e634.
PubMed Abstract available

ZIVADINOV R, Bergsland N, Hagemeier J, Ramasamy DP, et al
Cumulative gadodiamide administration leads to brain gadolinium deposition in early MS.
Neurology. 2019;93:e611-e623.
PubMed Abstract available

SNYDER J, Turner L
Crowdfunding for stem cell-based interventions to treat neurologic diseases and injuries.
Neurology. 2019;93:252-258.
PubMed Abstract available

HONORAT JA, Lopez-Chiriboga AS, Kryzer TJ, Komorowski L, et al
Autoimmune gait disturbance accompanying adaptor protein-3B2-IgG.
Neurology. 2019 Aug 1. pii: WNL.0000000000008061.
PubMed Abstract available

July 2019

HAPFELMEIER A, Gasperi C, Donnachie E, Hemmer B, et al
A large case-control study on vaccination as risk factor for multiple sclerosis.
Neurology. 2019 Jul 30. pii: WNL.0000000000008012.
PubMed Abstract available

SAUCEDO M, Chertcoff A, Bandeo L, Leon Cejas L, et al
Mystery Case: A 78-year-old man with a gait disorder.
Neurology. 2019;93:223-227.
PubMed

MANDEL-BREHM C, Retallack H, Knudsen GM, Yamana A, et al
Exploratory proteomic analysis implicates the alternative complement cascade in primary CNS vasculitis.
Neurology. 2019;93:e433-e444.
PubMed Abstract available

ALGAEED M
Author response: Pearls & Oy-sters: Pembrolizumab-induced myasthenia gravis.
Neurology. 2019;93:184.
PubMed

ROBBINS NM, Mozaffar T, Mammen AL, Liewluck T, et al
Reader response: Pearls & Oy-sters: Pembrolizumab-induced myasthenia gravis.
Neurology. 2019;93:183-184.
PubMed

GANESH A, Galetta S
Editors' note: Pearls & Oy-sters: Pembrolizumab-induced myasthenia gravis.
Neurology. 2019;93:182-183.
PubMed

MATEEN FJ
Multiple sclerosis in resource-limited settings: Research opportunities in an unequal world.
Neurology. 2019;93:176-180.
PubMed Abstract available

AL BANNA M, Reeder S, Ghannam M, Robertson J, et al
Teaching NeuroImages: A case of Vogt-Koyanagi-Harada disease with bilateral retinal detachment.
Neurology. 2019;93:e421.
PubMed

DE GIGLIO L, De Luca F, Gurreri F, Ferrante I, et al
Effect of dalfampridine on information processing speed impairment in multiple sclerosis.
Neurology. 2019 Jul 22. pii: WNL.0000000000007970.
PubMed Abstract available

TITULAER MJ, Irani SR, Lassmann H
PDE10A antibodies in autoimmune encephalitis: A possible marker of cancer immunotherapy?
Neurology. 2019 Jul 17. pii: WNL.0000000000007965.
PubMed

ZEKERIDOU A, Kryzer T, Guo Y, Hassan A, et al
Phosphodiesterase 10A IgG: A novel biomarker of paraneoplastic neurologic autoimmunity.
Neurology. 2019 Jul 17. pii: WNL.0000000000007971.
PubMed Abstract available

SCHMIDT M, Westemeier J, Gross D
The two lives of neurologist Helmut J. Bauer (1914-2008): Renowned MS specialist and National Socialist.
Neurology. 2019;93:109-113.
PubMed Abstract available

LAPLAUD DA, Casey R, Barbin L, Debouverie M, et al
Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis.
Neurology. 2019 Jul 12. pii: WNL.0000000000007938.
PubMed Abstract available

HERSH CM, Marrie RA
Harnessing real-world data to inform treatment decisions in multiple sclerosis.
Neurology. 2019 Jul 12. pii: WNL.0000000000007934.
PubMed

JONSSON DI, Sveinsson O, Hakim R, Brundin L, et al
Epidemiology of NMOSD in Sweden from 1987 to 2013: A nationwide population-based study.
Neurology. 2019;93:e181-e189.
PubMed Abstract available

CICHOWSKI AJ, Lawson VH
Patient hand and artistic depiction of chronic inflammatory demyelinating polyradiculoneuropathy.
Neurology. 2019;93:35-36.
PubMed

June 2019

SECHI E, Shosha E, Williams JP, Pittock SJ, et al
Aquaporin-4 and MOG autoantibody discovery in idiopathic transverse myelitis epidemiology.
Neurology. 2019 Jun 24. pii: WNL.0000000000007828.
PubMed Abstract available

DI LUCA DG, Landman J, Ortega MR, Gultekin SH, et al
Clinical Reasoning: A 47-year-old man with diffuse white matter disease and rapidly progressive dementia.
Neurology. 2019;92:e2832-e2837.
PubMed

VERBOON C, Doets AY, Galassi G, Davidson A, et al
Current treatment practice of Guillain-Barre syndrome.
Neurology. 2019 Jun 7. pii: WNL.0000000000007719.
PubMed Abstract available

GESSANI A, Cavallieri F, Budriesi C, Zucchi E, et al
Pearls & Oy-sters: Paroxysmal dysarthria-ataxia syndrome: Acoustic analysis in a case of antiphospholipid syndrome.
Neurology. 2019;92:e2727-e2731.
PubMed

May 2019

WAUBANT E, Banwell B, Wassmer E, Sormani MP, et al
Clinical trials of disease-modifying agents in pediatric MS: Opportunities, challenges, and recommendations from the IPMSSG.
Neurology. 2019;92:e2538-e2549.
PubMed Abstract available

HOWARD JF JR, Bril V, Burns TM, Mantegazza R, et al
Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis.
Neurology. 2019 May 22. pii: WNL.0000000000007600.
PubMed Abstract available

GUIDON AC, Juel VC
Efgartigimod: A novel antibody depletion therapy in myasthenia gravis.
Neurology. 2019 May 22. pii: WNL.0000000000007605.
PubMed

LANNUZEL A, Ferge JL, Lobjois Q, Signate A, et al
Long-term outcome in neuroZika: When biological diagnosis matters.
Neurology. 2019;92:e2406-e2420.
PubMed Abstract available

MAMMELE S, Thompson KS, Abe KK
A rapidly fatal case of anti-NMDA receptor encephalitis due to acute brain edema and herniation.
Neurology. 2019;92:1014-1016.
PubMed

MCKAY KA, Hillert J, Manouchehrinia A
Long-term disability progression ofpediatric-onset multiple sclerosis.
Neurology. 2019 May 15. pii: WNL.0000000000007647.
PubMed Abstract available

NA S, Lee ES, Kim YD
Teaching NeuroImages: Pterygoid myositis mimicking giant cell arteritis.
Neurology. 2019;92:e2297.
PubMed

DE BRUIJN MAAM, van Sonderen A, van Coevorden-Hameete MH, Bastiaansen AEM, et al
Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABABR encephalitis.
Neurology. 2019;92:e2185-e2196.
PubMed Abstract available

PAPADOPOULOU A, Gaetano L, Pfister A, Altermatt A, et al
Damage of the lateral geniculate nucleus in MS: Assessing the missing node of the visual pathway.
Neurology. 2019;92:e2240-e2249.
PubMed Abstract available

BLANKENBACH K, Schwab N, Hofner B, Adams O, et al
Natalizumab-associated progressive multifocal leukoencephalopathy in Germany.
Neurology. 2019;92:e2232-e2239.
PubMed Abstract available

CALABRESE M, Gasperini C, Tortorella C, Schiavi G, et al
"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study.
Neurology. 2019 May 1. pii: WNL.0000000000007573.
PubMed Abstract available

BROWNLEE WJ
Differential diagnosis of multiple sclerosis: The better explanations in clinical practice.
Neurology. 2019 May 1. pii: WNL.0000000000007566.
PubMed

April 2019

DI LUCA DG, De Leon-Benedetti A, Williamson S, Irving LT, et al
Teaching Video NeuroImages: A patient with Holmes tremor due to demyelinating lesion of the inferior cerebellar peduncle.
Neurology. 2019;92:e2179-e2180.
PubMed

MAILLART E, Mochel F, Acquaviva C, Maisonobe T, et al
Severe transient myopathy in a progressive multiple sclerosis patient with high-dose biotin.
Neurology. 2019 Apr 26. pii: WNL.0000000000007576.
PubMed

ZHANG C, Wang SG, Wang Y, Liu XL, et al
Teaching Video NeuroImages: Cautious walking gait in siblings with hereditary hyperekplexia.
Neurology. 2019;92:e2068-e2069.
PubMed

VILLOSLADA P, Green AJ, Galetta S
Personalizing medical care for MS patients: Monitoring brainstem damage by infrared oculography.
Neurology. 2019 Apr 19. pii: WNL.0000000000007493.
PubMed

NIJ BIJVANK JA, van Rijn LJ, Balk LJ, Tan HS, et al
Diagnosing and quantifying a common deficit in multiple sclerosis: Internuclear ophthalmoplegia.
Neurology. 2019 Apr 19. pii: WNL.0000000000007499.
PubMed Abstract available

BURON MD, Chalmer TA, Sellebjerg F, Frederiksen J, et al
Comparative effectiveness of teriflunomide and dimethyl fumarate: A nationwide cohort study.
Neurology. 2019;92:e1811-e1820.
PubMed Abstract available

BRITTON JW, Dalmau J
Recognizing autoimmune encephalitis as a cause of seizures: Treating cause and not effect.
Neurology. 2019 Apr 12. pii: WNL.0000000000007444.
PubMed

MEHTA D, Miller C, Arnold DL, Bame E, et al
Effect of dimethyl fumarate on lymphocytes in RRMS: Implications for clinical practice.
Neurology. 2019;92:e1724-e1738.
PubMed Abstract available

KILLESTEIN J, Reder AT
Dimethyl fumarate-induced changes in the MS lymphocyte repertoire: No need for subset monitoring.
Neurology. 2019;92:696-697.
PubMed

WAUBANT E, Gilmore W
Mind the gap: Quantifying gender representation as a first step to solve the problem?
Neurology. 2019;92:698-699.
PubMed

CORTESE M, Chitnis T, Ascherio A, Munger KL, et al
Total intake of different minerals and the risk of multiple sclerosis.
Neurology. 2019 Apr 3. pii: WNL.0000000000006800.
PubMed Abstract available

MCDONNELL GV, Marriott JJ
Patient-perceived risks of MS DMTs: Problems of communication and risk management?
Neurology. 2019;92:647-648.
PubMed

JOHANSEN A, Christensen SJ, Scheie D, Hojgaard JLS, et al
Neuromuscular adverse events associated with anti-PD-1 monoclonal antibodies: Systematic review.
Neurology. 2019;92:663-674.
PubMed Abstract available

MARRIE RA, Garland A, Schaffer SA, Fransoo R, et al
Traditional risk factors may not explain increased incidence of myocardial infarction in MS.
Neurology. 2019;92:e1624-e1633.
PubMed Abstract available

March 2019

CONWAY DS
What is the impact of socioeconomic status on multiple sclerosis?
Neurology. 2019;92:e1536-e1539.
PubMed

GORIS A, Dubois B
Leveraging human genetics to inform intervention strategies for multiple sclerosis.
Neurology. 2019 Mar 20. pii: WNL.0000000000007298.
PubMed

THOMSON A, Horne R, Chung C, Marta M, et al
Visibility and representation of women in multiple sclerosis research.
Neurology. 2019 Mar 20. pii: WNL.0000000000007276.
PubMed Abstract available

HARROUD A, Morris JA, Forgetta V, Mitchell R, et al
Effect of age at puberty on risk of multiple sclerosis: A mendelian randomization study.
Neurology. 2019 Mar 20. pii: WNL.0000000000007325.
PubMed Abstract available

KALINCIK T
Effectiveness of oral multiple sclerosis therapies in clinical context.
Neurology. 2019 Mar 15. pii: WNL.0000000000007300.
PubMed

DE MEO E, Meani A, Moiola L, Ghezzi A, et al
Dynamic gray matter volume changes in pediatric multiple sclerosis: A 3.5-year MRI study.
Neurology. 2019 Mar 13. pii: WNL.0000000000007267.
PubMed Abstract available

FOX RJ, Cosenza C, Cripps L, Ford P, et al
A survey of risk tolerance to multiple sclerosis therapies.
Neurology. 2019 Mar 13. pii: WNL.0000000000007245.
PubMed Abstract available

YEH EA, Eshaghi A
Evolution of regional brain atrophy in children with multiple sclerosis: Gray matters.
Neurology. 2019 Mar 13. pii: WNL.0000000000007254.
PubMed

BAR-OR A, Grove RA, Tolson JM, Derosier FJ, et al
Author response: Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis: The MIRROR study.
Neurology. 2019;92:543.
PubMed

KEARNEY H
Reader response: Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis: The MIRROR study.
Neurology. 2019;92:542-543.
PubMed

LEWIS A, Galetta S
Editors' note: Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis: The MIRROR study.
Neurology. 2019;92:542.
PubMed

YEH EA, Nakashima I
Live-cell based assays are the gold standard for anti-MOG-Ab testing.
Neurology. 2019;92:501-502.
PubMed

NG PS, Dyck PJ, Laughlin RS, Thapa P, et al
Lumbosacral radiculoplexus neuropathy: Incidence and the association with diabetes mellitus.
Neurology. 2019;92:e1188-e1194.
PubMed Abstract available

WATERS PJ, Komorowski L, Woodhall M, Lederer S, et al
A multicenter comparison of MOG-IgG cell-based assays.
Neurology. 2019;92:e1250-e1255.
PubMed Abstract available

LAPUCCI C, Saitta L, Bommarito G, Sormani MP, et al
How much do periventricular lesions assist in distinguishing migraine with aura from CIS?
Neurology. 2019 Mar 8. pii: WNL.0000000000007266.
PubMed Abstract available

CULPEPPER WJ, Marrie RA, Langer-Gould A, Wallin MT, et al
Validation of an algorithm for identifying MS cases in administrative health claims datasets.
Neurology. 2019;92:e1016-e1028.
PubMed Abstract available

WALLIN MT, Culpepper WJ, Campbell JD, Nelson LM, et al
The prevalence of MS in the United States: A population-based estimate using health claims data.
Neurology. 2019;92:e1029-e1040.
PubMed Abstract available

KUHLE J, Kropshofer H, Haering DA, Kundu U, et al
Blood neurofilament light chain as a biomarker of MS disease activity and treatment response.
Neurology. 2019;92:e1007-e1015.
PubMed Abstract available

ZULUAGA MI, Otero-Romero S, Rovira A, Perez-Hoyos S, et al
Menarche, pregnancies, and breastfeeding do not modify long-term prognosis in multiple sclerosis.
Neurology. 2019 Mar 1. pii: WNL.0000000000007178.
PubMed Abstract available

CASAL-DOMINGUEZ M, Pinal-Fernandez I, Corse AM, Paik J, et al
Muscular and extramuscular features of myositis patients with anti-U1-RNP autoantibodies.
Neurology. 2019 Mar 1. pii: WNL.0000000000007188.
PubMed Abstract available

February 2019

HARDING KE, Wardle M, Carruthers R, Robertson N, et al
Socioeconomic status and disability progression in multiple sclerosis: A multinational study.
Neurology. 2019 Feb 22. pii: WNL.0000000000007190.
PubMed Abstract available

OH J, Ontaneda D, Azevedo C, Klawiter EC, et al
Imaging outcome measures of neuroprotection and repair in MS: A consensus statement from NAIMS.
Neurology. 2019 Feb 20. pii: WNL.0000000000007099.
PubMed Abstract available

KOCH-HENRIKSEN N
Author response: Incidence of MS has increased markedly over 6 decades in Denmark particularly with late onset and in women.
Neurology. 2019;92:397.
PubMed

SAJEDI SA
Reader response: Incidence of MS has increased markedly over 6 decades in Denmark particularly with late onset and in women.
Neurology. 2019;92:397.
PubMed

BENARROCH EE
Autonomic nervous system and neuroimmune interactions: New insights and clinical implications.
Neurology. 2019;92:377-385.
PubMed

DI LUCA DG, Bette S, Singer C, Luca C, et al
Teaching NeuroImages: Severe spasms resembling status dystonicus as an unusual presentation of stiff-person syndrome.
Neurology. 2019;92:e748.
PubMed

SECHI E, Parks NE, Koeller KK, Flanagan EP, et al
Hypertrophic olivary degeneration mimics relapse in neuromyelitis optica spectrum disorder.
Neurology. 2019;92:343-344.
PubMed

DALLA COSTA G, Martinelli V, Sangalli F, Moiola L, et al
Prognostic value of serum neurofilaments in patients with clinically isolated syndromes.
Neurology. 2019;92:e733-e741.
PubMed Abstract available

ROCHA EA, Topcuoglu MA, Silva GS, Singhal AB, et al
RCVS2 score and diagnostic approach for reversible cerebral vasoconstriction syndrome.
Neurology. 2019;92:e639-e647.
PubMed Abstract available

BERGER T, Stuve O
Neurofilament light chain: An important step toward a disease biomarker in multiple sclerosis.
Neurology. 2019 Feb 8. pii: WNL.0000000000007022.
PubMed

XU SC, Kardon RH, Leavitt JA, Flanagan EP, et al
Optical coherence tomography is highly sensitive in detecting prior optic neuritis.
Neurology. 2019;92:e527-e535.
PubMed Abstract available

January 2019

COHEN J, Sotoca J, Gandhi S, Yeshokumar AK, et al
Autoimmune encephalitis: A costly condition.
Neurology. 2019 Jan 23. pii: WNL.0000000000006990.
PubMed Abstract available

BERGER JR, Cree BA, Greenberg B, Hemmer B, et al
Author response: Progressive multifocal leukoencephalopathy after fingolimod treatment.
Neurology. 2019;92:151.
PubMed

LALIVE PH, Roth S, Du Pasquier R
Reader response: Progressive multifocal leukoencephalopathy after fingolimod treatment.
Neurology. 2019;92:151.
PubMed

RUEGG S, Yeh EA, Honnorat J
Forecasting outcomes in anti-NMDAR encephalitis: Clearer prognostic markers needed.
Neurology. 2019;92:119-120.
PubMed

BALU R, McCracken L, Lancaster E, Graus F, et al
A score that predicts 1-year functional status in patients with anti-NMDA receptor encephalitis.
Neurology. 2019;92:e244-e252.
PubMed Abstract available

ZETTERBERG H, Svenningsson A
Serum neurofilament light and prediction of multiple sclerosis in clinically isolated syndrome.
Neurology. 2019 Jan 11. pii: WNL.0000000000006906.
PubMed

HONCE JM, Nair KV, Sillau S, Valdez B, et al
Rituximab vs placebo induction prior to glatiramer acetate monotherapy in multiple sclerosis.
Neurology. 2019 Jan 11. pii: WNL.0000000000006916.
PubMed Abstract available

COHEN BA
Late-onset neutropenia following ocrelizumab therapy for multiple sclerosis.
Neurology. 2019 Jan 11. pii: WNL.0000000000006924.
PubMed

Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Neurology. 2019;92:112.
PubMed

RAE-GRANT A
Author response: Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Neurology. 2019;92:110-111.
PubMed

SALTONSTALL L
Reader response: Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Neurology. 2019;92:109-110.
PubMed

LEWIS A, Galetta S
Editors' note: Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Neurology. 2019;92:109.
PubMed

December 2018

PAPPOLLA A, Midaglia L, Boix Rodriguez CP, Puig AA, et al
Simultaneous CMV and Listeria infection following alemtuzumab treatment for multiple sclerosis.
Neurology. 2018 Dec 26. pii: WNL.0000000000006801.
PubMed

GASPERINI C, Prosperini L, Tintore M, Sormani MP, et al
Unraveling treatment response in multiple sclerosis: A clinical and MRI challenge.
Neurology. 2018 Dec 26. pii: WNL.0000000000006810.
PubMed Abstract available

November 2018

MARRIE RA, Butzkueven H, Ascherio A
Obesity and brain volume loss in multiple sclerosis.
Neurology. 2018 Nov 14. pii: WNL.0000000000006638.
PubMed

MAHLER C, Unterrainer M, Muth C, Egensperger R, et al
Imaging microglial activation in tacrolimus-associated CNS vasculitis with translocator protein PET.
Neurology. 2018;91:936-937.
PubMed

RUCK T, Pfeuffer S, Schulte-Mecklenbeck A, Gross CC, et al
Vitiligo after alemtuzumab treatment: Secondary autoimmunity is not all about B cells.
Neurology. 2018 Nov 7. pii: WNL.0000000000006648.
PubMed Abstract available

October 2018

BROWNLEE WJ
Misdiagnosis of multiple sclerosis: If you have a hammer, everything looks like a nail?
Neurology. 2018 Oct 31. pii: WNL.0000000000006584.
PubMed

SOLOMON AJ, Naismith RT, Cross AH
Misdiagnosis of multiple sclerosis: Impact of the 2017 McDonald criteria on clinical practice.
Neurology. 2018 Oct 31. pii: WNL.0000000000006583.
PubMed Abstract available

PORTACCIO E, Amato MP
Author response: Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks.
Neurology. 2018;91:851.
PubMed

SOTGIU S, Eusebi A, Begliuomini C, Guerini FR, et al
Reader response: Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks.
Neurology. 2018;91:850.
PubMed

PROSCHMANN U, Akgun K, Ziemssen T
Reader response: Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks.
Neurology. 2018;91:849-850.
PubMed

LEWIS A, Galetta S
Editors' note: Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks.
Neurology. 2018;91:849.
PubMed

KRYSKO KM, Graves J, Rensel M, Weinstock-Guttman B, et al
Use of newer disease-modifying therapies in pediatric multiple sclerosis in the US.
Neurology. 2018 Oct 17. pii: WNL.0000000000006471.
PubMed Abstract available

BASAL E, Zalewski N, Kryzer TJ, Hinson SR, et al
Paraneoplastic neuronal intermediate filament autoimmunity.
Neurology. 2018 Oct 3. pii: WNL.0000000000006435.
PubMed Abstract available

ALGAEED M, Mukharesh L, Heinzelmann M, Kaminski HJ, et al
Pearls & Oy-sters: Pembrolizumab-induced myasthenia gravis.
Neurology. 2018;91:e1365-e1367.
PubMed

September 2018

CAVALLA P, Gilmore W
Pregnancy in multiple sclerosis: Data from an administrative claims database.
Neurology. 2018 Sep 28. pii: WNL.0000000000006371.
PubMed

BAHEERATHAN A, McNamara C, Kalam S, Rane N, et al
The utility of FDG-PET imaging in distinguishing PML-IRIS from PML in a patient treated with natalizumab.
Neurology. 2018;91:572-573.
PubMed

Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis: The MIRROR study.
Neurology. 2018;91:538.
PubMed

August 2018

MIDAGLIA L, Gratacos M, Caronna E, Raguer N, et al
Myasthenia gravis following alemtuzumab therapy for multiple sclerosis.
Neurology. 2018 Aug 24. pii: WNL.0000000000006251.
PubMed

RUDANT J, Dupont A, Mikaeloff Y, Bolgert F, et al
Surgery and risk of Guillain-Barre syndrome: A French nationwide epidemiologic study.
Neurology. 2018 Aug 24. pii: WNL.0000000000006246.
PubMed Abstract available

BROWNLEE WJ, Miszkiel KA, Tur C, Barkhof F, et al
Inclusion of optic nerve involvement in dissemination in space criteria for multiple sclerosis.
Neurology. 2018 Aug 17. pii: WNL.0000000000006207.
PubMed Abstract available

July 2018

BEDARF JR, Nelles M, Reimann J, Paus S, et al
Teaching Video NeuroImages: Propriospinal myoclonus as a sequela of Guillain-Barre syndrome.
Neurology. 2018;91:e297-e299.
PubMed

MARQUES-MATOS C, Melo C, Sampaio M, Rodrigues E, et al
Child Neurology: Treatable bilateral striatal lesions related to anti-dopamine 2 receptor autoimmunity.
Neurology. 2018;91:98-101.
PubMed

June 2018

TSAGKAS C, Magon S, Gaetano L, Pezold S, et al
Spinal cord volume loss: A marker of disease progression in multiple sclerosis.
Neurology. 2018 Jun 27. pii: WNL.0000000000005853.
PubMed Abstract available

PRADOS F, Barkhof F
Spinal cord atrophy rates: Ready for prime time in multiple sclerosis clinical trials?
Neurology. 2018 Jun 27. pii: WNL.0000000000005873.
PubMed

HAGENS MHJ, Burggraaff J, Kilsdonk ID, de Vos ML, et al
Three-Tesla MRI does not improve the diagnosis of multiple sclerosis: A multicenter study.
Neurology. 2018 Jun 20. pii: WNL.0000000000005825.
PubMed Abstract available

VITT JR, Kreple C, Mahmood N, Dickerson E, et al
Autoimmune pancerebellitis associated with pembrolizumab therapy.
Neurology. 2018 Jun 6. pii: WNL.0000000000005781.
PubMed

PROSPERINI L, Lucchini M, Haggiag S, Bellantonio P, et al
Fingolimod vs dimethyl fumarate in multiple sclerosis: A real-world propensity score-matched study.
Neurology. 2018 Jun 6. pii: WNL.0000000000005772.
PubMed Abstract available

May 2018

LEHMANN HC, Compston A, Hartung HP
150th anniversary of clinical description of multiple sclerosis: Leopold Ordenstein's legacy.
Neurology. 2018;90:1011-1016.
PubMed Abstract available

KIM DD, Ho C, King R, Morrow SA, et al
Pearls & Oy-sters: An unusual neuropsychiatric manifestation of systemic lupus erythematosus.
Neurology. 2018;90:e1929-e1932.
PubMed

LIEWLUCK T
Author response: Anti-cytosolic 5'-nucleotidase 1A (cN1A) autoantibodies in motor neuron diseases.
Neurology. 2018;90:990.
PubMed

BUDHRAM A
Reader response: Anti-cytosolic 5'-nucleotidase 1A (cN1A) autoantibodies in motor neuron diseases.
Neurology. 2018;90:990.
PubMed

KARAM C, Galetta S
Editors' note: Anti-cytosolic 5'-nucleotidase 1A (cN1A) autoantibodies in motor neuron diseases.
Neurology. 2018;90:989.
PubMed

SCALFARI A, Romualdi C, Nicholas RS, Mattoscio M, et al
The cortical damage, early relapses, and onset of the progressive phase in multiple sclerosis.
Neurology. 2018 May 16. pii: WNL.0000000000005685.
PubMed Abstract available

SHANKLIN A, Cox A, Ahmed HMA, Lieberman A, et al
Clinical Reasoning: A 77-year-old man presenting with episodic expressive aphasia.
Neurology. 2018;90:e1822-e1826.
PubMed

DE LORENZO R, Pinal-Fernandez I, Huang W, Albayda J, et al
Muscular and extramuscular clinical features of patients with anti-PM/Scl autoantibodies.
Neurology. 2018 May 4. pii: WNL.0000000000005638.
PubMed Abstract available

FRANKLIN GM, McDonnell G
Free health care, great data, and new clues on multiple sclerosis.
Neurology. 2018 May 2. pii: WNL.0000000000005593.
PubMed

LOPEZ CHIRIBOGA AS, Matsumoto J, Sorenson E, Klein CJ, et al
Teaching Video NeuroImages: Acquired focal neuromyotonia in LGI-1 autoimmunity.
Neurology. 2018;90:e1636-e1637.
PubMed

April 2018

GERARDI C, Bertele' V, Rossi S, Garattini S, et al
Preapproval and postapproval evidence on drugs for multiple sclerosis.
Neurology. 2018 Apr 25. pii: WNL.0000000000005561.
PubMed Abstract available

BAR-OR A, Grove RA, Austin DJ, Tolson JM, et al
Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis: The MIRROR study.
Neurology. 2018 Apr 25. pii: WNL.0000000000005516.
PubMed Abstract available

COBO-CALVO A, Ruiz A, Maillart E, Audoin B, et al
Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: The MOGADOR study.
Neurology. 2018 Apr 25. pii: WNL.0000000000005560.
PubMed Abstract available

RAE-GRANT A, Day GS, Marrie RA, Rabinstein A, et al
Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Neurology. 2018;90:789-800.
PubMed Abstract available

RAE-GRANT A, Day GS, Marrie RA, Rabinstein A, et al
Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Neurology. 2018;90:777-788.
PubMed Abstract available

HEWETT K, Sanders DB, Grove RA, Broderick CL, et al
Randomized study of adjunctive belimumab in participants with generalized myasthenia gravis.
Neurology. 2018;90:e1425-e1434.
PubMed Abstract available

PEDROSO JL, Dutra LA, Espay AJ, Hoftberger R, et al
Video NeuroImages: Head titubation in anti-mGluR1 autoantibody-associated cerebellitis.
Neurology. 2018;90:746-747.
PubMed

CORREALE J, Ysrraelit MC, Benarroch EE
Metabolic coupling of axons and glial cells: Implications for multiple sclerosis progression.
Neurology. 2018;90:737-744.
PubMed

March 2018

FERRARO D, Camera V, Vitetta F, Zennaro M, et al
Acute coronary syndrome associated with alemtuzumab infusion in multiple sclerosis.
Neurology. 2018 Mar 30. pii: WNL.0000000000005417.
PubMed

SAARELA M, Senthil K, Jones J, Tienari PJ, et al
Hemophagocytic lymphohistiocytosis in 2 patients with multiple sclerosis treated with alemtuzumab.
Neurology. 2018 Mar 30. pii: WNL.0000000000005420.
PubMed

FRATTINI E, Monfrini E, Bitetto G, Ferrari B, et al
Clinical Reasoning: A 75-year-old man with parkinsonism, mood depression, and weight loss.
Neurology. 2018;90:572-575.
PubMed

ROTSTEIN DL, Chen H, Wilton AS, Kwong JC, et al
Temporal trends in multiple sclerosis prevalence and incidence in a large population.
Neurology. 2018 Mar 16. pii: WNL.0000000000005331.
PubMed Abstract available

GAETANO L, Haring DA, Radue EW, Mueller-Lenke N, et al
Fingolimod effect on gray matter, thalamus, and white matter in patients with multiple sclerosis.
Neurology. 2018 Mar 14. pii: WNL.0000000000005292.
PubMed Abstract available

SCHOONHEIM MM, Ciccarelli O
The value of including thalamic atrophy as a clinical trial endpoint in multiple sclerosis.
Neurology. 2018 Mar 14. pii: WNL.0000000000005279.
PubMed

MCKAY KA, Tremlett H, Fisk JD, Zhang T, et al
Psychiatric comorbidity is associated with disability progression in multiple sclerosis.
Neurology. 2018 Mar 9. pii: WNL.0000000000005302.
PubMed Abstract available

MILLER AE, Calabresi PA
Central vein sign in multiple sclerosis: Ready for front and center?
Neurology. 2018 Mar 7. pii: WNL.0000000000005241.
PubMed

TREMLETT H, Zhu F, Ascherio A, Munger KL, et al
Sun exposure over the life course and associations with multiple sclerosis.
Neurology. 2018 Mar 7. pii: WNL.0000000000005257.
PubMed Abstract available

February 2018

PATIL A, Shree R, Naheed D, Goyal MK, et al
Pearls & Oy-sters: Paraneoplastic cerebral vasculitis: Rare cause of spontaneous convexity subarachnoid hemorrhage.
Neurology. 2018;90:e815-e817.
PubMed

CHATAWAY J, Martin K, Barrell K, Sharrack B, et al
Effects of ATX-MS-1467 immunotherapy over 16 weeks in relapsing multiple sclerosis.
Neurology. 2018 Feb 21. pii: WNL.0000000000005118.
PubMed Abstract available

BATEMAN EM, Schleicher WE, Smith EJ, Sweet DR, et al
Journal Club: MRI reveals acute inflammation in cortical lesions during early MS.
Neurology. 2018;90:e724-e726.
PubMed Abstract available

PORTACCIO E, Annovazzi P, Ghezzi A, Zaffaroni M, et al
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks.
Neurology. 2018 Feb 7. pii: WNL.0000000000005067.
PubMed Abstract available

PORTACCIO E, Moiola L, Martinelli V, Annovazzi P, et al
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks.
Neurology. 2018 Feb 7. pii: WNL.0000000000005068.
PubMed Abstract available

ALROUGHANI R, Alowayesh MS, Ahmed SF, Behbehani R, et al
Relapse occurrence in women with multiple sclerosis during pregnancy in the new treatment era.
Neurology. 2018 Feb 2. pii: WNL.0000000000005065.
PubMed Abstract available

SALVARANI C, Brown RD Jr, Christianson TJH, Huston J 3rd, et al
Primary central nervous system vasculitis associated with lymphoma.
Neurology. 2018 Feb 2. pii: WNL.0000000000005062.
PubMed Abstract available

January 2018

BENNETT S, Leavitt VM
An intervention to improve balance in persons with multiple sclerosis.
Neurology. 2018 Jan 31. pii: WNL.0000000000005038.
PubMed

HEBERT JR, Corboy JR, Vollmer T, Forster JE, et al
Efficacy of Balance and Eye-Movement Exercises for Persons With Multiple Sclerosis (BEEMS).
Neurology. 2018 Jan 31. pii: WNL.0000000000005013.
PubMed Abstract available

WEHRUM T, Beume LA, Stich O, Mader I, et al
Activation of disease during therapy with alemtuzumab in 3 patients with multiple sclerosis.
Neurology. 2018 Jan 19. pii: WNL.0000000000004950.
PubMed Abstract available

PETERSEN ER, Oturai AB, Koch-Henriksen N, Magyari M, et al
Smoking affects the interferon beta treatment response in multiple sclerosis.
Neurology. 2018 Jan 17. pii: WNL.0000000000004949.
PubMed Abstract available

SUMOWSKI JF, Benedict R, Enzinger C, Filippi M, et al
Cognition in multiple sclerosis: State of the field and priorities for the future.
Neurology. 2018 Jan 17. pii: WNL.0000000000004977.
PubMed Abstract available

ALLENBACH Y, Arouche-Delaperche L, Preusse C, Radbruch H, et al
Necrosis in anti-SRP(+) and anti-HMGCR(+)myopathies: Role of autoantibodies and complement.
Neurology. 2018 Jan 12. pii: WNL.0000000000004923.
PubMed Abstract available

ZHANG T, Tremlett H, Zhu F, Kingwell E, et al
Effects of physical comorbidities on disability progression in multiple sclerosis.
Neurology. 2018 Jan 3. pii: WNL.0000000000004885.
PubMed Abstract available

December 2017

PISA M, Guerrieri S, Di Maggio G, Medaglini S, et al
No evidence of disease activity is associated with reduced rate of axonal retinal atrophy in MS.
Neurology. 2017;89:2469-2475.
PubMed Abstract available

DUBEY D, Lennon VA, Gadoth A, Pittock SJ, et al
Autoimmune CRMP5 neuropathy phenotype and outcome defined from 105 cases.
Neurology. 2017 Dec 8. pii: WNL.0000000000004803.
PubMed Abstract available

LOREFICE L, Fenu G, Gerevini S, Frau J, et al
PML in a person with multiple sclerosis: Is teriflunomide the felon?
Neurology. 2017 Dec 6. pii: WNL.0000000000004804.
PubMed

FITZGERALD KC, Tyry T, Salter A, Cofield SS, et al
Diet quality is associated with disability and symptom severity in multiple sclerosis.
Neurology. 2017 Dec 6. pii: WNL.0000000000004768.
PubMed Abstract available

SUMOWSKI JF, McDonnell GV, Bourdette D
Diet in multiple sclerosis: Science takes a seat at the table.
Neurology. 2017 Dec 6. pii: WNL.0000000000004775.
PubMed

November 2017

BURNOR E, Yang L, Zhou H, Patterson KR, et al
Neurofascin antibodies in autoimmune, genetic, and idiopathic neuropathies.
Neurology. 2017 Nov 29. pii: WNL.0000000000004773.
PubMed Abstract available

KLAWITER EC, Bove R, Elsone L, Alvarez E, et al
High risk of postpartum relapses in neuromyelitis optica spectrum disorder.
Neurology. 2017;89:2238-2244.
PubMed Abstract available

LARONI A, Signori A, Maniscalco GT, Lanzillo R, et al
Assessing association of comorbidities with treatment choice and persistence in MS: A real-life multicenter study.
Neurology. 2017;89:2222-2229.
PubMed Abstract available

KARCESKI S
How comorbid conditions affect the choice of treatment in multiple sclerosis.
Neurology. 2017;89:e265-e267.
PubMed

DHAWAN PS, Dyck PJB, Tracy JA, Naddaf E, et al
Systemic vasculitis with dermatomyositis, hearing loss, neuropathy, and multiorgan dysfunction.
Neurology. 2017;89:2119-2120.
PubMed

KOWALEC K, McKay KA, Patten SB, Fisk JD, et al
Comorbidity increases the risk of relapse in multiple sclerosis: A prospective study.
Neurology. 2017 Nov 8. pii: 10.1212/WNL.0000000000004716.
PubMed Abstract available

BURMAN J, Zelano J
Epilepsy in multiple sclerosis: A nationwide population-based register study.
Neurology. 2017 Nov 8. pii: 10.1212/WNL.0000000000004740.
PubMed Abstract available

HOUZEN H, Kondo K, Niino M, Horiuchi K, et al
Prevalence and clinical features of neuromyelitis optica spectrum disorders in northern Japan.
Neurology. 2017;89:1995-2001.
PubMed Abstract available

ARRAMBIDE G, Tintore M, Auger C, Rio J, et al
Lesion topographies in multiple sclerosis diagnosis: A reappraisal.
Neurology. 2017 Nov 3. pii: 10.1212/WNL.0000000000004715.
PubMed Abstract available

BARNETT C, Bril V, Kapral M, Kulkarni AV, et al
Myasthenia Gravis Impairment Index: Responsiveness, meaningful change, and relative efficiency.
Neurology. 2017 Nov 3. pii: 10.1212/WNL.0000000000004676.
PubMed Abstract available

October 2017

NOVAKOVA L, Zetterberg H, Sundstrom P, Axelsson M, et al
Monitoring disease activity in multiple sclerosis using serum neurofilament light protein.
Neurology. 2017 Oct 27. pii: 10.1212/WNL.0000000000004683.
PubMed Abstract available

CHIANG S, Kesari NK, Bradshaw A, Chen W, et al
Pearls & Oy-sters: CNS lymphoma in a patient with relapsing-remitting multiple sclerosis treated with interferon.
Neurology. 2017;89:e210-e213.
PubMed

MATHIS S, Magy L, Le Masson G, Vallat JM, et al
Did Jules Dejerine describe AMAN at the end of the 19th century?
Neurology. 2017;89:1749-1753.
PubMed Abstract available

KARGIOTIS O, Safouris A, Petrou VN, Magoufis G, et al
Teaching NeuroImages: Giant cell arteritis presenting with acute ischemic strokes due to diffuse intracranial stenoses.
Neurology. 2017;89:e190-e191.
PubMed

TSIVGOULIS G, Papadimitropoulos GN, Katsanos AH, Zompola C, et al
Teaching NeuroImages: Interferon-induced psoriasis flare in a multiple sclerosis case remits with dimethyl fumarate.
Neurology. 2017;89:e188-e189.
PubMed

MUNGER KL, Hongell K, Aivo J, Soilu-Hanninen M, et al
25-Hydroxyvitamin D deficiency and risk of MS among women in the Finnish Maternity Cohort.
Neurology. 2017;89:1578-1583.
PubMed Abstract available

September 2017

LIEWLUCK T
Anti-cytosolic 5'-nucleotidase 1A (cN1A) autoantibodies in motor neuron diseases.
Neurology. 2017 Sep 27. pii: 10.1212/WNL.0000000000004610.
PubMed

KARCESKI S
Multiple sclerosis, inflammation in the brain, and mood.
Neurology. 2017;89:e169-e171.
PubMed

MARRIE RA, Salter A, Tyry T, Cutter GR, et al
Author response: High hypothetical interest in physician-assisted death in multiple sclerosis.
Neurology. 2017;89:1429-1430.
PubMed

SETHI NK
Letter re: High hypothetical interest in physician-assisted death in multiple sclerosis and Physician-assisted death in chronic neurologic diseases.
Neurology. 2017;89:1429.
PubMed

MASDEU JC
Letter re: High hypothetical interest in physician-assisted death in multiple sclerosis.
Neurology. 2017;89:1428.
PubMed

THORMANN A, Sorensen PS, Koch-Henriksen N, Laursen B, et al
Comorbidity in multiple sclerosis is associated with diagnostic delays and increased mortality.
Neurology. 2017 Sep 20. pii: 10.1212/WNL.0000000000004508.
PubMed Abstract available

PLAVINA T, Muralidharan KK, Kuesters G, Mikol D, et al
Reversibility of the effects of natalizumab on peripheral immune cell dynamics in MS patients.
Neurology. 2017 Sep 15. pii: 10.1212/WNL.0000000000004485.
PubMed Abstract available

MARRIE RA, Beck CA
Preventing multiple sclerosis: To (take) vitamin D or not to (take) vitamin D?
Neurology. 2017 Sep 13. pii: 10.1212/WNL.0000000000004506.
PubMed

LOPEZ-CHIRIBOGA AS, Clardy SL
Emerging Subspecialties in Neurology: Autoimmune neurology.
Neurology. 2017;89:e129-e133.
PubMed

FILLI L, Zorner B, Killeen T, Linnebank M, et al
Author response: Monitoring long-term efficacy of fampridine in gait-impaired patients with multiple sclerosis.
Neurology. 2017;89:1200.
PubMed

DAVIS FA
Letter re: Monitoring long-term efficacy of fampridine in gait-impaired patients with multiple sclerosis.
Neurology. 2017;89:1199.
PubMed

COLES AJ, Cohen JA, Fox EJ, Giovannoni G, et al
Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findings.
Neurology. 2017;89:1117-1126.
PubMed Abstract available

HAVRDOVA E, Arnold DL, Cohen JA, Hartung HP, et al
Alemtuzumab CARE-MS I 5-year follow-up: Durable efficacy in the absence of continuous MS therapy.
Neurology. 2017;89:1107-1116.
PubMed Abstract available

LORSCHEIDER J, Jokubaitis VG, Spelman T, Izquierdo G, et al
Anti-inflammatory disease-modifying treatment and short-term disability progression in SPMS.
Neurology. 2017;89:1050-1059.
PubMed Abstract available

August 2017

LANGER-GOULD A, Wu J, Lucas R, Smith J, et al
Epstein-Barr virus, cytomegalovirus, and multiple sclerosis susceptibility: A multiethnic study.
Neurology. 2017 Aug 30. pii: 10.1212/WNL.0000000000004412.
PubMed Abstract available

HENNES EM, Baumann M, Schanda K, Anlar B, et al
Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome.
Neurology. 2017;89:900-908.
PubMed Abstract available

ROSSI S, Studer V, Motta C, Polidoro S, et al
Neuroinflammation drives anxiety and depression in relapsing-remitting multiple sclerosis.
Neurology. 2017 Aug 25. pii: 10.1212/WNL.0000000000004411.
PubMed Abstract available

KOCH-HENRIKSEN N, Lauer K
Dietary sodium intake: An etiologic dead end in multiple sclerosis.
Neurology. 2017 Aug 25. pii: 10.1212/WNL.0000000000004426.
PubMed

CORTESE M, Yuan C, Chitnis T, Ascherio A, et al
No association between dietary sodium intake and the risk of multiple sclerosis.
Neurology. 2017 Aug 25. pii: 10.1212/WNL.0000000000004417.
PubMed Abstract available

WIENDL H, Bourdette D, Ciccarelli O
Can immune reprogramming with alemtuzumab induce permanent remission in multiple sclerosis?
Neurology. 2017 Aug 23. pii: 10.1212/WNL.0000000000004381.
PubMed

DE MEO E, Moiola L, Ghezzi A, Veggiotti P, et al
MRI substrates of sustained attention system and cognitive impairment in pediatric MS patients.
Neurology. 2017 Aug 18. pii: 10.1212/WNL.0000000000004388.
PubMed Abstract available

SUZUKI S, Ishikawa N, Konoeda F, Seki N, et al
Nivolumab-related myasthenia gravis with myositis and myocarditis in Japan.
Neurology. 2017 Aug 18. pii: 10.1212/WNL.0000000000004359.
PubMed Abstract available

BEECHER G, Anderson D, Siddiqi ZA
Subcutaneous immunoglobulin in myasthenia gravis exacerbation: A prospective, open-label trial.
Neurology. 2017 Aug 16. pii: 10.1212/WNL.0000000000004365.
PubMed Abstract available

Escalation therapy for multiple sclerosis in Austria: Analysis of gender differences in the nationwide registry.
Neurology. 2017;89:752.
PubMed

HEHIR MK, Hobson-Webb LD, Benatar M, Barnett C, et al
Rituximab as treatment for anti-MuSK myasthenia gravis: Multicenter blinded prospective review.
Neurology. 2017 Aug 11. pii: 10.1212/WNL.0000000000004341.
PubMed Abstract available

July 2017

NIELSEN NM, Munger KL, Stenager E, Ascherio A, et al
Author response: Neonatal vitamin D status and risk of multiple sclerosis: A population-based case-control study.
Neurology. 2017;89:411.
PubMed

XIA Z, Cheng Q, Li J
Letter re: Neonatal vitamin D status and risk of multiple sclerosis: A population-based case-control study.
Neurology. 2017;89:410-411.
PubMed

ZARGHAMI A
Letter re: Neonatal vitamin D status and risk of multiple sclerosis: A population-based case-control study.
Neurology. 2017;89:410.
PubMed

MARANZANO J, Rudko DA, Nakamura K, Cook S, et al
MRI evidence of acute inflammation in leukocortical lesions of patients with early multiple sclerosis.
Neurology. 2017 Jul 19. pii: 10.1212/WNL.0000000000004227.
PubMed Abstract available

HACOHEN Y, Mankad K, Chong WK, Barkhof F, et al
Diagnostic algorithm for relapsing acquired demyelinating syndromes in children.
Neurology. 2017;89:269-278.
PubMed Abstract available

LANGER-GOULD A, Smith JB, Hellwig K, Gonzales E, et al
Breastfeeding, ovulatory years, and risk of multiple sclerosis.
Neurology. 2017 Jul 12. pii: 10.1212/WNL.0000000000004207.
PubMed Abstract available

Autologous hematopoietic stem cell transplantation in multiple sclerosis: A meta-analysis.
Neurology. 2017;89:215.
PubMed

URUHA A, Suzuki S, Nishino I
Author update: Sarcoplasmic MxA expression: A valuable marker of dermatomyositis.
Neurology. 2017;89:215.
PubMed

BURKILL S, Montgomery S, Hajiebrahimi M, Hillert J, et al
Mortality trends for multiple sclerosis patients in Sweden from 1968 to 2012.
Neurology. 2017 Jul 7. pii: 10.1212/WNL.0000000000004216.
PubMed Abstract available

June 2017

LEWIS EJH, Perkins BA, Lovblom LE, Bazinet RP, et al
Effect of omega-3 supplementation on neuropathy in type 1 diabetes: A 12-month pilot trial.
Neurology. 2017;88:2294-2301.
PubMed Abstract available

DE JONG HJI, Kingwell E, Shirani A, Cohen Tervaert JW, et al
Evaluating the safety of beta-interferons in MS: A series of nested case-control studies.
Neurology. 2017;88:2310-2320.
PubMed Abstract available

BRENNA G, Antozzi C, Montomoli C, Baggi F, et al
A propensity score analysis for comparison of T-3b and VATET in myasthenia gravis.
Neurology. 2017 Jun 7. pii: 10.1212/WNL.0000000000004082.
PubMed Abstract available

May 2017

BATISTA S, Alves C, d'Almeida OC, Afonso A, et al
Disconnection as a mechanism for social cognition impairment in multiple sclerosis.
Neurology. 2017 May 31. pii: 10.1212/WNL.0000000000004060.
PubMed Abstract available

SOLOMON AJ, Weinshenker BG
Author response: The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study.
Neurology. 2017;88:2067-2068.
PubMed

DALLA COSTA G, Martinelli V, Comi G
Letter re: The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study.
Neurology. 2017;88:2067.
PubMed

ESHAGHI A, Ciccarelli O
Author response: Gray matter MRI differentiates neuromyelitis optica from multiple sclerosis using random forest.
Neurology. 2017;88:1875.
PubMed

AVASARALA J
Letter re: Gray matter MRI differentiates neuromyelitis optica from multiple sclerosis using random forest.
Neurology. 2017;88:1875.
PubMed

TIMMINGS PL, Siu R, Bukhari W, Todd A, et al
Author response: Acute Zika infection with concurrent onset of Guillain-BarrE syndrome.
Neurology. 2017;88:1874-1875.
PubMed

GERARDIN P, Cao-Lormeau VM, Tournebize P, Cerny T, et al
Letter re: Acute Zika infection with concurrent onset of Guillain-BarrE syndrome.
Neurology. 2017;88:1874.
PubMed

MEIJER KA, Eijlers AJC, Douw L, Uitdehaag BMJ, et al
Increased connectivity of hub networks and cognitive impairment in multiple sclerosis.
Neurology. 2017 May 3. pii: 10.1212/WNL.0000000000003982.
PubMed Abstract available

AUBERT-BROCHE B, Weier K, Longoni G, Fonov VS, et al
Monophasic demyelination reduces brain growth in children.
Neurology. 2017;88:1744-1750.
PubMed Abstract available

GAIG C, Graus F, Compta Y, Hogl B, et al
Clinical manifestations of the anti-IgLON5 disease.
Neurology. 2017;88:1736-1743.
PubMed Abstract available

April 2017

SORMANI MP, Muraro PA, Schiavetti I, Signori A, et al
Autologous hematopoietic stem cell transplantation in multiple sclerosis: A meta-analysis.
Neurology. 2017 Apr 28. pii: 10.1212/WNL.0000000000003987.
PubMed Abstract available

GIANFRANCESCO MA, Stridh P, Rhead B, Shao X, et al
Evidence for a causal relationship between low vitamin D, high BMI, and pediatric-onset MS.
Neurology. 2017;88:1623-1629.
PubMed Abstract available

NUNLEY KA, Leckie RL, Orchard TJ, Costacou T, et al
Physical activity and hippocampal volume in middle-aged patients with type 1 diabetes.
Neurology. 2017;88:1564-1570.
PubMed Abstract available

MADDISON P, Gozzard P, Grainge MJ, Lang B, et al
Long-term survival in paraneoplastic Lambert-Eaton myasthenic syndrome.
Neurology. 2017;88:1334-1339.
PubMed Abstract available

March 2017

LANDI D, De Rossi N, Zagaglia S, Scarpazza C, et al
No evidence of beneficial effects of plasmapheresis in natalizumab-associated PML.
Neurology. 2017;88:1144-1152.
PubMed Abstract available

ABSINTA M, Cortese IC, Vuolo L, Nair G, et al
Leptomeningeal gadolinium enhancement across the spectrum of chronic neuroinflammatory diseases.
Neurology. 2017 Mar 10. pii: 10.1212/WNL.0000000000003820.
PubMed Abstract available

February 2017

NASH RA, Hutton GJ, Racke MK, Popat U, et al
High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS.
Neurology. 2017;88:842-852.
PubMed Abstract available

KUHLE J, Nourbakhsh B, Grant D, Morant S, et al
Serum neurofilament is associated with progression of brain atrophy and disability in early MS.
Neurology. 2017;88:826-831.
PubMed Abstract available

MOWRY EM, McArthur JC
PML in natalizumab-treated multiple sclerosis: Modeling errors and risk miscalculations.
Neurology. 2017 Feb 22. pii: 10.1212/WNL.0000000000003749.
PubMed

MOLKO N, Simon O, Guyon D, Biron A, et al
Zika virus infection and myasthenia gravis: Report of 2 cases.
Neurology. 2017 Feb 10. pii: 10.1212/WNL.0000000000003697.
PubMed

BARTON J, Hardy TA, Riminton S, Reddel SW, et al
Tumefactive demyelination following treatment for relapsing multiple sclerosis with alemtuzumab.
Neurology. 2017 Feb 8. pii: 10.1212/WNL.0000000000003694.
PubMed

WYNN DP, Donigan JM, Tkach A
Clinical Reasoning: A 74-year-old woman with bilateral foot pain and a palmar rash.
Neurology. 2017;88:e44-e50.
PubMed

BODINI B, Calabresi PA
From neurofilament research to multiple sclerosis clinical practice: Where do we stand?
Neurology. 2017 Feb 1. pii: 10.1212/WNL.0000000000003676.
PubMed

BENNETT SE
Fampridine: Long-term benefits in walking in multiple sclerosis.
Neurology. 2017 Feb 1. pii: 10.1212/WNL.0000000000003677.
PubMed

January 2017

SCHEIBE F, Pruss H, Mengel AM, Kohler S, et al
Bortezomib for treatment of therapy-refractory anti-NMDA receptor encephalitis.
Neurology. 2017;88:366-370.
PubMed Abstract available

MAAROUF A, Audoin B, Pariollaud F, Gherib S, et al
Increased total sodium concentration in gray matter better explains cognition than atrophy in MS.
Neurology. 2017;88:289-295.
PubMed Abstract available

December 2016

ROCCA MA, Battaglini M, Benedict RH, De Stefano N, et al
Brain MRI atrophy quantification in MS: From methods to clinical application.
Neurology. 2016 Dec 16. pii: 10.1212/WNL.0000000000003542.
PubMed Abstract available

GOEDEE HS, van der Pol WL, van Asseldonk JH, Franssen H, et al
Diagnostic value of sonography in treatment-naive chronic inflammatory neuropathies.
Neurology. 2016 Dec 7. pii: 10.1212/WNL.0000000000003483.
PubMed Abstract available

November 2016

TENSER RB, Truini A, Cruccu G
A dual concurrent mechanism explains trigeminal neuralgia in patients with multiple sclerosis.
Neurology. 2016;87:2385-2386.
PubMed

BEADNALL HN, Gill AJ, Riminton S, Barnett MH, et al
Virus-related Merkel cell carcinoma complicating fingolimod treatment for multiple sclerosis.
Neurology. 2016 Nov 16. pii: 10.1212/WNL.0000000000003434.
PubMed

October 2016

BOURDETTE D
Rituximab for treating multiple sclerosis: Off-label but on target.
Neurology. 2016 Oct 19. pii: 10.1212/WNL.0000000000003345.
PubMed

September 2016

KANTOR D, Sotirchos ES, Calabresi PA
Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis.
Neurology. 2016;87:1424.
PubMed

KELLY DM, Kelleher EM, O'Shea A, Sweeney B, et al
Teaching Video NeuroImages: Primary writing tremor: Lessons from a patient with multiple sclerosis.
Neurology. 2016;87:e131.
PubMed

ARNOLD DL, Fisher E, Brinar VV, Cohen JA, et al
Superior MRI outcomes with alemtuzumab compared with subcutaneous interferon beta-1a in MS.
Neurology. 2016 Sep 2. pii: 10.1212/WNL.0000000000003169.
PubMed Abstract available

July 2016

SIU R, Bukhari W, Todd A, Gunn W, et al
Acute Zika infection with concurrent onset of Guillain-Barre Syndrome.
Neurology. 2016 Jul 27. pii: 10.1212/WNL.0000000000003038.
PubMed

BROWNLEE WJ, Swanton JK, Miszkiel KA, Miller DH, et al
Should the symptomatic region be included in dissemination in space in MRI criteria for MS?
Neurology. 2016 Jul 15. pii: 10.1212/WNL.0000000000002975.
PubMed Abstract available

FERREIRA DA SILVA IR, Frontera JA, Moreira do Nascimento OJ
News from the battlefront: Zika virus-associated Guillain-BarrE Syndrome in Brazil.
Neurology. 2016 Jul 15. pii: 10.1212/WNL.0000000000003024.
PubMed

May 2016

KOELMAN DL, Chahin S, Mar SS, Venkatesan A, et al
Acute disseminated encephalomyelitis in 228 patients: A retrospective, multicenter US study.
Neurology. 2016;86:2085-93.
PubMed Abstract available

HYUN JW, Jeong IH, Joung A, Kim SH, et al
Evaluation of the 2015 diagnostic criteria for neuromyelitis optica spectrum disorder.
Neurology. 2016;86:1772-9.
PubMed Abstract available

SPATOLA M, Du Pasquier R, Schluep M, Regeniter A, et al
Serum and CSF GQ1b antibodies in isolated ophthalmologic syndromes.
Neurology. 2016;86:1780-4.
PubMed Abstract available

KASSAVETIS P, Joseph JB, Francois R, Perloff MD, et al
Zika virus-associated Guillain-Barre syndrome variant in Haiti.
Neurology. 2016 May 6. pii: 10.1212/WNL.0000000000002759.
PubMed

VAN SONDEREN A, Schreurs MW, de Bruijn MA, Boukhrissi S, et al
The relevance of VGKC positivity in the absence of LGI1 and Caspr2 antibodies.
Neurology. 2016;86:1692-9.
PubMed Abstract available

MELINYSHYN AN, Gofton TE, Schulz V
Supernumerary phantom limbs in ICU patients with acute inflammatory demyelinating polyneuropathy.
Neurology. 2016;86:1726-8.
PubMed Abstract available

April 2016

DE LOTT LB, Burke JF, Kerber KA, Skolarus LE, et al
Medicare Part D payments for neurologist-prescribed drugs.
Neurology. 2016;86:1491-8.
PubMed Abstract available

March 2016

HODEL J, Darchis C, Outteryck O, Verclytte S, et al
Punctate pattern: A promising imaging marker for the diagnosis of natalizumab-associated PML.
Neurology. 2016 Mar 23. pii: 10.1212/WNL.0000000000002586.
PubMed Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: